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ABSTRACT 
 
Biological rhythms are critical for the timing of hormone secretion, reproduction, 
and rest-wake activity patterns. Sex differences in daily (circadian) rhythms have been 
described for a number of species including humans. Women have a higher incidence of 
sleep disorders than men and are twice as likely to have difficulty falling and staying 
asleep. Additionally, women report sleep problems that change across their menstrual 
cycle and during the peri-menopausal period. Hormone replacement studies in women 
and in animals indicate that estrogen can modify the expression of daily rhythms; 
however, the exact mechanism and sites of action for steroid hormones have not been 
determined. Understanding the relationship of gonadal hormones on the normal 
functioning of circadian rhythms will shed light on the etiology of sex differences in 
sleep disorders and the basic mechanisms of hormonal regulation of activity patterns. The 
overarching goal of my research is to determine the mechanisms by which estrogens can 
modify circadian rhythms both during development and in the adult animal.  I 
hypothesize that estrogens modify the expression of daily and circadian rhythms via the 
estrogen receptor subtype 1 (ESR1) and via “non-classical” estrogenic mechanisms. I 
hypothesize that impaired estrogen signaling results in a decreased sensitivity to the light-
dark cues that allow normal circadian entrainment.  
To test these hypotheses I determined if estrogen receptor 1 (ESR1) is necessary 
for normal entrainment to the light-dark (LD) cycle and for the expression of circadian 
rhythms in activity by characterizing circadian entrainment in intact NERKI and ERKO 
mice. I also quantified free-running parameters in intact NERKI and ERKO mice and 
compared them to wildtype (WT) counterparts (Chapter 1). To determine if estrogens 
alter the ability to respond to changes in the LD cycle via the ESR1 and/or non-classical 
estrogen signaling, I quantified and compared the behavioral response to light pulse in 
NERKI and ERKO male and female mice. I also measured the cellular response to light 
pulse to test the hypothesis that behavioral shifts in light response are mediated through 
the master circadian clock, the suprachiasmatic nucleus (SCN) (Chapter 2). In addition to 
describing how impaired response to estrogens at ESR1 modifies circadian rhythms and 
patterns of daily activity in intact NERKI and ERKO mice, I determined the 
developmental role of estrogens acting at ESR1 and via non-classical mechanisms by 
examining circadian behaviors in gonadectomized NERKI and ERKO male and female 
mice. Specifically, I characterized the circadian behavior of male and female 
gonadectomized mice with and without estradiol replacement in entrainment and free-
running conditions (Chapter 3, 4). Finally, I confirmed the organizational and activational 
roles of estrogenic modification of circadian rhythms via an ESR1-mediated mechanism 
by looking at the expression of circadian behaviors with ESR1 over-expressing mice 
(EROE). I quantified the activity patterns of intact EROE male and female mice in 
entrained and free-running conditions, and established a role of ESR1 on organization of 
circadian rhythms during development by looking at behavior of gonadectomized EROE 
mice compared to control littermates (Chapter 5). 
I hypothesized that estrogens acting via both organizational and activational 
mechanisms influence the development and the expression of circadian behaviors in 
adulthood. I have established that the differential ability to respond to estrogens at ESR1 
results in differences in entrainment and circadian rhythms (Chapter 1) and behavioral 
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response to light (Chapter 2). Genotype and sex differences that are present in 
gonadectomized mice indicate that estrogens acting via ESR1 and “non-classical” 
pathways during development permanently change circadian rhythms (Chapters 3 and 4). 
Lastly, I characterized the daily activity patterns in ESR1 over-expressing mice that have 
heightened response to circulating estrogen, which indicate that estrogens modulate 
circadian behaviors via organizational and activational action at ESR1 (Chapter 5). 
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 1 
BACKGROUND 
 
I. Sex differences in sleep and circadian rhythms 
There are sex differences in the epidemiology of sleep disorders. Women have a 
higher incidence of some sleep disorders than do men and are twice as likely to report 
difficulty falling and staying asleep. Although sleep complaints are more common in 
women than in men, women are underrepresented in studies of sleep and sleep disorders 
(“The National Sleep Disorders Research Plan” (2003)). Objective measures of healthy 
sleep indicate that women have increased REM sleep, shorter sleep onset latency, longer 
sleep times, and increased sleep efficiency compared to men. However, women also have 
increased sleep complaints and increased incidence of sleep disorders, such as insomnia 
(Krishnan and Collop, 2006). In addition to sex differences in healthy sleep, disruptions 
in daily rhythms due to shift work or jet-lag lead to significant health consequences in 
women. Shift work has recently been recognized as a clinically-relevant circadian 
disruption. Tolerance to shift work depends on age, personality type, and gender; males 
tend to tolerate circadian disruption due to shift work more than females do (Saksvik et 
al., 2011). There is an increasing body of evidence that female shift workers have poorer 
sleep quality, increased reproductive disorders, increased risk of breast cancer, and 
increased metabolic and cardiovascular disorders relative to males (Chung et al., 2009). 
In women, perturbed biological rhythms are correlated with difficulty achieving 
pregnancy, a higher risk of producing low birth weight babies, spontaneous abortion, 
subfecundity and irregular menstrual cycles accompanied by changes in secretion 
patterns of ovarian and pituitary hormones (Mahoney, 2010). Thus, it is critical that 
research explores circadian rhythms in females. By further characterizing the 
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mechanisms of estrogen regulation of circadian rhythms, especially in response to light, I 
will better understand why women are especially vulnerable to the health consequences 
of chronic circadian disruption. 
The regulatory role of gonadal hormones on circadian rhythms has important 
implications for understanding the physiological architecture of sleep, mechanisms 
underlying sleep disorders, development of therapeutic targets, and women’s health 
broadly. In human and laboratory animal studies, sex differences in circadian rhythms are 
rarely taken into account. For example, a study identifying an optimal time of day for 
chemotherapy found that males showed greatly improved outcomes. However, the same 
treatment protocol that improved outcomes in men, actually increased mortality in 
women (Giacchetti et al., 2006). Sex differences in clinical outcomes may be amplified or 
masked in studies that control for treatment time, as the fundamental daily rhythms of 
men and women differ. Some of the first conclusive reports of sex differences in humans 
have only been reported in the past 12 months. The daily rhythms in body temperature 
and melatonin production are set earlier in women than men, and women have preference 
for morning activities compared to men (Duffy et al., 2011). Women also have a shorter 
intrinsic circadian period than men have; however, the neurobiological mechanisms that 
underlie these sex differences are unknown.  
Animal studies provide strong evidence that the steroid hormone environment 
during development and circulating steroid hormones in adults result in sex differences in 
the expression of biological rhythms. There are sex differences in the pattern of daily 
activity, level of activity, period of free-running activity, and day-to-day consistency of 
activity in intact hamsters (Davis et al., 1983). These sex differences in period and 
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activity duration persist following gonadectomy of mice (Iwahana et al., 2008) 
suggesting hormone exposure over the lifetime contributes to the expression of circadian 
rhythms. Although these sex differences can be attributed in part to circulating steroid 
hormones, relatively little research has examined the mechanisms that underlie these sex 
differences in humans or laboratory animals. 
The overall goal of my research is to determine the mechanisms by which 
estrogen exposure across the lifespan contributes to sex differences in circadian 
rhythms. Ultimately, a better characterization of the hormonal modulation of circadian 
rhythms—and how this modulation depends on sex differences—will provide insight into 
the etiology of sex differences in circadian rhythms, responses to circadian disruption, 
and sleep disorders. 
 
II. Bidirectional interactions of estrogens and circadian rhythms 
 The regulatory roles of estrogens on the expression of circadian rhythms in adults 
have been suggested by both the sex differences in circadian parameters across a variety 
of species and supported by experiments with gonadectomy and estradiol replacement. In 
intact animals, the sex differences in circadian rhythms and changes in activity patterns 
across the reproductive, or estrous, cycle in females suggest a role of ovarian hormones, 
specifically estrogens. In hamsters, there is modulation in total wheel running activity 
depending on estrous stage; high estradiol levels increase total wheel-running activity and 
phase advance the timing of nocturnal activity (Morin et al., 1977). Wheel-running 
activity begins about 30 minutes earlier on days of high circulating estrogen levels 
(Axelson et al., 1981). In the diurnal rodent, Octodon degus, there is an increase in 
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activity level and a phase advance during the time of estrus (Labyak and Lee, 1995, 
Mahoney et al., 2011). In rats, the onset of activity relative to the dark phase and duration 
of the active period (alpha) varied throughout the estrous cycle with the most advanced 
phase angle and greatest duration of the active period on the day of estrus (Albers et al., 
1981). In women, sleep parameters and the amplitude of body temperature rhythms 
change from the follicular to luteal phases of the menstrual cycle, suggesting that ovarian 
hormones modify these daily rhythms in humans as well as laboratory animals 
(Leibenluft, 1993, Parry et al., 1997, Shibui et al., 2000). 
Estrogens modulate circadian activity in adult rodents, as demonstrated by 
ovariectomy and acute estradiol replacement. Estradiol administration shortens the free-
running period in constant light conditions in ovariectomized rodents (Morin et al., 1977, 
Albers, 1981). In addition to this ability of the biological rhythms of an adult to respond 
to estrogens, there is evidence that rhythms are organized over the lifetime by exposure to 
steroid hormones during development. Albers (1981) examined this issue by injecting 
gonadectomized/ ovariectomized neonatal male and female rat pups with testosterone. 
This perinatal exposure to androgens contributed to sex differences in free-running period 
(tau) in adulthood. In the adult females not exposed to perinatal androgens, estradiol 
administration after ovariectomy shortened free-running period. However, in adult 
females exposed to perinatal androgens, estradiol treatment shortened or lengthened tau 
in proportion to and inversely related to the pre-treatment length of free-running period. 
In gonadectomized male rats with free-running rhythms greater than 24 hours, estrogen 
replacement shortened the free-running period, and the greatest shortening of the period 
was in animals with the longest intact free-running period. Conversely, in males with 
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free-running periods shorter than 24 hours, estrogen increased the period (Albers, 1981). 
In both testosterone-treated females and males, therefore, the response to estrogen was 
the same and was different than the response of untreated females. 
In addition to the influence of estrogens on rhythms in daily activity, the inverse 
relationship is also true: daily environmental cues like the light-dark (LD) cycle regulate 
the timing of reproductive events. In hamsters, environmental LD cues modify the release 
of luteinizing hormone (LH) to stimulate ovulation; interruption of the circadian system 
will interrupt the estrous cycle (Fitzgerald and Zucker, 1976).  
There is evidence that a daily signal regulates the timing of these reproductive 
events. In female rats, the estrous cycle is coupled to the 24-hour LD cycle (Everett and 
Sawyer, 1950). Fitzgerald and Zucker (1976) demonstrated that hamsters in free-running 
conditions have an estrous cycle that is a fourfold multiple of the circadian wheel-running 
rhythm in the entrained state. That is, each estrous cycle is four circadian days, even 
when the days were lengthened during the free-running cycle in constant darkness. In 
constant dim light rats show free-running estrous cycles (McCormack and Sridaran, 
1978) and in constant light conditions, bright light disrupts estrous cycles by inhibition of 
the LH surge.  
Alterations in light-dark patterns by experimental phase shifts further illustrate the 
interaction between estrous cycles and circadian rhythms. Following a three-hour phase 
advance in the external LD cycle, hamsters take about four days to re-entrain wheel-
running behavior to the new light cycle. Correspondingly, rhythmicity in their estrous 
cycles and the timing of the preovulatory LH surge takes several days to phase shift 
(Moline and Albers, 1988). The influence of light environment on estrous cyclicity over 
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the lifetime has been studied; in rats raised in constant light, there is a differential effect 
of constant light exposure on estrous cyclicity in adulthood compared to animals raised in 
LD conditions. Females raised in constant light were able to maintain cyclicity in contrast 
to rats exposed to constant light in adulthood that then lost estrous cyclicity in constant 
light (Hagino et al., 1983). The timing of the LH surge is coupled to endogenous 
circadian rhythms, rather than patterns of light-dark cues (Moline et al., 1981). This 
further supports the hypothesis that reproductive function, such as intact estrous cycles, 
depends on regulation from the circadian system, rather than on external day-night light 
cues, or zietgebers.  
In addition to physiological changes in circadian behavior and locomotor activity 
during the reproductive cycle there are increased reports of sleep disturbances throughout 
the lifespan that correlate with changes in circulating hormones. The development of the 
circadian system during puberty may depend on the presence of gonadal hormones. In 
both humans and rodents, there is a phase delay in activity rhythms during puberty 
relative to adults; in rodents there are greater sex differences in circadian parameters 
during puberty when compared to sex differences in adults (Hagenauer, 2011). In 
humans, adolescent females have a greater tendency to be morning-active than adolescent 
males (Randler, 2011). Sex differences in the expression of circadian rhythms, including 
free-running period and phase angle of activity onset, in the Octodon degus depend on 
exposure to circulating gonadal hormones during puberty (Hummer, 2007).  
The perimenopausal period is an additional epoch characterized by changes in 
hormone secretion patterns in women. Sleep disturbances are a chief complaint of these 
females, suggesting a role of estrogens in biological rhythms. As many as 64% of per-
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menopausal women experience sleep disturbances in the form of reduced sleep efficiency 
with sleep initiation and maintenance difficulties (Moline et al., 2003). Women taking 
hormone replacement therapy report more efficient sleep, earlier sleep onsets, and fewer 
nighttime awakenings indicating an interaction between endocrine signals and circadian 
rhythms (Xu et al., 2011).  
  
III. The Suprachiasmatic nucleus and steroid hormones 
 The suprachiasmatic nucleus (SCN) is the central oscillator that regulates rhythms 
in daily timing of physiology and behavior (Nunez and Stephan, 1977, Stephan and 
Nunez, 1977). In rodents, damage to the SCN disrupts regulation of reproductive 
cyclicity. The SCN is located in the anterior ventral hypothalamus, dorsal to the optic 
chiasm, where it integrates endogenous rhythms with exogenous light cues. The retina 
sends direct neuronal projections to the ventromedial portion (or core) that in turn sends 
signals to the medial and dorsal area (or shell). Light pulses given to animals housed in 
the dark leads to an increase in the expression of transcription factors and “clock genes” 
in the SCN, reflecting a “re-setting” of the endogenous clock (Abizaid et al., 2004). 
Lesions of the SCN lead to desynchrony in daily activity, distribution of sleep, and in 
females, abolish the estrous cycle (Nunez and Stephan, 1977). 
There is evidence of sexual dimorphism in the SCN that depends on gonadal 
steroid exposure during development. For example, female rats have increased neuronal 
differentiation in the SCN during late gestation compared to males and this sex difference 
is abolished when animals are exposed to testosterone during late gestation (Abizaid et 
al., 2004). There are gonadal hormone receptors in the SCN of rodents and humans. The 
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human SCN has progesterone receptors and estrogen receptors (ESR1 and ESR2), with 
significantly greater ESR1 expression in females relative to males (Kruijver and Swaab, 
2002). The distribution of nuclear estrogen receptors in the mouse SCN has been mapped 
via immuno-labeling. Both ESR1 and ESR2 have been reported in the mouse SCN (Vida 
et al., 2008) and there is higher expression of ESR2 relative to ESR1 throughout the 
mouse SCN. The ESR1 population extends throughout the rostral-caudal extent of the 
SCN and is present to a greater extent in the shell region than the core region of the SCN. 
This anatomy is somewhat controversial; Mitra et al., (2003) visualized ESR1 and ESR2 
in the mouse brain with immunolocalization and found that ESR1 and ESR2 are both 
distributed in the hypothalamus (Mitra et al., 2003), however, they report no ESR1 and 
questionable ESR2 in the mouse SCN. The ventromedial nucleus of the hypothalamus 
and the lateral hypothalamic area have also been implicated in circadian oscillation with 
communications to and from the SCN (Koizumi and Nishino, 1976); ESR1 and ESR2 are 
present in both of these regions in the mouse brain (Mitra et al., 2003). In humans, there 
are subtle differences in the shape of the SCN and differences in age-related changes in 
SCN morphology (Hofman et al., 1988). It remains unclear whether these morphological 
differences relate to the functional sex differences observed in biological rhythms.  
Recent studies indicate that circulating androgens may also underlie significant 
sex differences in circadian rhythms. For example, castrated male mice given back 
testosterone or the non-aromatized androgen, dihydrotestosterone, have an increase in 
activity (Karatsoreos et al., 2007, Iwahana et al., 2008). A detailed look at the SCN 
reveals that males have significantly more androgen receptor expression in the SCN than 
females do (Iwahana et al., 2008). These results do not rule out the significant role 
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estrogens play in modifying rhythms. It is possible that sex hormones regulate circadian 
rhythms, with androgens as the primary regulator of rhythms in males and estrogens as 
the primary regulator in females.  
 
IV. Pathway of estrogenic signaling and transgenic mouse models 
Although it is well-established that intact circadian rhythms are necessary for 
female reproductive rhythms, the mechanism of the interaction between these circadian 
and endocrine rhythms is unclear. It is clear that gonadal hormones, specifically 
estrogens, influence circadian rhythms, but where they act and how they regulate rhythms 
remains unclear. Also, the effect of response to circulating estrogens during development 
and their modification of circadian rhythms in the adult animal have not been fully 
explored. To untangle the mechanism of estrogen modulation and organization of 
circadian rhythms, I am using a series of transgenic mice. These mice allow me to look at 
specific point disruptions in estrogen response pathways and to look at how the 
differential ability to respond to circulating estrogens over the lifespan alter the 
expression of circadian rhythms in adulthood. I will look at the acute effects of 
circulating estrogen and also the developmental and organizational roles that estrogens 
play in modulating circadian rhythms in behavior and physiology. 
Estrogens are involved in a diverse array of physiological functions in multiple 
tissues; they have a role in cell growth, differentiation, and specific organ functions 
(Katzenellenbogen et al., 2000). Estrogenic action is mediated through at least two 
distinct nuclear receptors: ESR1 and ESR2, extensively reviewed (Hall et al., 2001, 
Kousteni et al., 2001) as well as more recently characterized “non-classical” pathways. 
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To exert action via nuclear receptor-mediated transcriptional activation, estrogens bind to 
nuclear receptors, which undergo a conformational change promoting dimerization. The 
hormone-receptor complex dimer then binds to the estrogen response element (ERE) on 
regulatory regions of target genes to alter gene transcription. This is considered 
“classical” estrogen signaling (Figure 1). In addition to this “classical” mechanism of 
estrogen activity, there are other “non-classical” mechanisms of estrogen responsiveness. 
These alternative pathways include actions at non-ERE transcription factors, membrane-
initiated action via protein kinases, and ligand-independent estrogen receptor signaling 
via second messenger pathways, described (McDevitt et al., 2008). 
Figure 1: Classical estrogen action at nuclear receptors. Estrogens bind to nuclear steroid 
receptors, which form dimers and bind to estrogen response elements (ERE) on target 
genes to regulate transcription. 
 
To investigate how estrogens modify the circadian timing system I utilize three 
different strains of mice that have alterations in their ability to respond to estrogen at 
ESR1. Estrogen receptor alpha, or ESR1, knock-out (ERKO) and “non-classical” 
estrogen receptor knock-in (NERKI) mice have disruptions in their ability to respond to 
 11 
estrogens at ESR1 (Figure 2). In the ERKO mice, ESR1 have been knocked-out. In the 
NERKI mice, the knock-out of ESR1 is nuanced: NERKI mice have modified ESR1 
receptors such that there is a mutation in the ERE-binding domain of the protein. 
Estrogens can bind to the receptor, but the complexes cannot then bind to ERE to effect 
“classical” transcriptional activation within the cell. However, the estrogen-receptor 
complex may still act via non-classical (non-ERE-dependent) pathways (Jakacka et al., 
2002). This transgenic model allows us to identify the unique roles of estrogens that are 
not mediated by ERE-DNA binding to modify activity patterns.  
Finally, I will use ESR1 over-expressing mice (EROE) that have heightened 
sensitivity to circulating estrogens to confirm the influence of ESR1-mediated regulation 
of estrogens on circadian rhythms. Differences in the backgrounds of the NERKI/ERKO 
and EROE strains prevent direct comparisons between the groups (Schwartz and 
Zimmerman, 1990, Pugh et al., 2004), however, relative directions of the differences in 
circadian rhythm parameters can be compared. The comparisons between these strains 
provide a powerful tool for determining how hormone exposure during development 
leads to long-term changes in the adult. 
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Figure 2: The transgenic mice used in these studies have impaired responsiveness to 
estrogens at different points in the ESR1 pathway. 
 
 
These transgenic mice provide unique insight into the mechanism of estrogenic 
organization of circadian rhythms compared to WT mice that have been gonadectomized 
in adulthood because they have specific mutations at ESR1. These intact transgenic 
animals also allow us to characterize the behavior of mice with basal circulating gonadal 
hormones.  Further, these mice are uniquely suited to discerning how estrogens acting at 
ESR1 organize the expression of circadian rhythms over the lifespan, rather than how an 
acute disruption with gonadectomy or estrogen antagonist administration modifies 
behavior. 
Circulating hormone concentrations in ERKO, NERKI, and WT mice are 
relatively similar to one another, allowing us to compare between intact animals. 
Concentrations of FSH and LH in WT mice do not differ from ERKO (Eddy et al., 1996) 
and NERKI (Jakacka et al., 2002) mice. Relative to WT mice, circulating concentrations 
of estradiol are not significantly different in NERKI males and females (Jakacka et al., 
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2002). In female ERKO mice, circulating estradiol concentrations are increased 
compared to WT females (Couse et al., 1995) and in ERKO males testosterone levels are 
slightly elevated relative to WT males (Eddy et al., 1996). 
 Understanding the interaction between circadian rhythms and sex hormones has 
implications for better addressing clinical issues in sleep pathologies, the physiology of 
circadian disruption in shift work that makes women especially vulnerable to circadian 
disruption. As we establish that estrogens regulate the timing of sleep-wake activity 
patterns via modulation of the response to light, we can better understand the regulatory 
role of gonadal hormones on the normal functioning of circadian rhythms. This will 
contribute to our understanding of sex differences in sleep disorders and circadian 
behaviors. 
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CHAPTER 1 
 
Circadian parameters are altered in two strains of mice with transgenic 
modifications of estrogen receptor subtype 1 
 
 
Abstract:  
There are sex differences in free-running rhythms, activity level, and activity distribution 
that are attributed, in part, to the action of gonadal hormones. We tested the hypothesis 
that estrogens modify the amplitude and phase of activity via estrogen receptor subtype 1 
(ESR1) and non-classical signaling pathways. We used ESR1 knock-out mice (ERKO) 
and non-classical estrogen receptor knock-in mice (NERKI). ERKO animals are unable 
to respond to estrogen at the ESR1 and NERKI animals lack the ability to respond to 
estrogens via the estrogen response element-mediated pathway, but can still respond via 
non-classical mechanisms. We compared intact male and female ERKO, NERKI, and 
wildtype (WT) mice with respect to total wheel-running activity, activity distribution 
across the 24-hour day, phase angle of activity onset, and free-running period (tau) and 
the duration of activity in constant conditions. WT females had significantly greater 
activity than WT males and this activity was more consolidated to the dark phase of the 
light:dark cycle. These sex differences were absent in the NERKI and ERKO animals. 
Among females, NERKI and ERKO animals had greater activity during the light phase 
than WT counterparts. Additionally, we have identified a novel contribution of non-
classical estrogen signaling pathways on the distribution of activity. Our data suggest that 
total activity is ESR1-dependent and daily activity patterns depend on both classical and 
non-classical actions of estrogens. These data will aid in identifying the mechanisms 
underlying sex differences in sleep-wake cycles and the influence of steroid hormones on 
circadian patterns. 
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Introduction:  
In humans there are sex differences in circadian rhythms and the epidemiology of 
healthy sleep and sleep disorders. Objective measures of healthy sleep find sex 
differences in the total amount of sleep, sleep onset latency, and sleep efficiency; there 
are also sex differences in the prevalence of some sleep disorders, including insomnia, 
restless leg syndrome, and sleep apnea, reviewed in (Krishnan and Collop, 2006). The 
intrinsic circadian period of melatonin secretion and body temperature is set earlier in 
women than men even when the same bedtimes and wake times are maintained (Duffy et 
al., 2011). Further, in women, sleep parameters and the amplitude of body temperature 
rhythms change from the follicular to luteal phases of the menstrual cycle and change in 
post-menopausal women following hormone replacement therapy. Together these data 
suggest that ovarian hormones modify these daily and circadian rhythms (Leibenluft, 
1993, Parry et al., 1997, Shibui et al., 2000). 
Animal studies provide strong evidence that exposure to steroid hormones during 
development and circulating steroid hormones in adults result in sex differences in the 
expression of biological rhythms, including sleep-wake patterns. In female rodents, total 
daily wheel-running activity depends on the stage of the reproductive cycle; when 
estrogens are elevated there is an increase in both total wheel-running activity and a 
phase advance in the timing of the daily activity onset in hamsters (Morin et al., 1977), 
degus (Labyak and Lee, 1995, Mahoney et al., 2011), and rats (Wollnik and Turek, 
1988). In rats, the duration of the active period (alpha) in constant conditions and in a 
light:dark cycle varies throughout the estrous cycle with the greatest duration of the 
active period occurring on the day of estrus (Albers et al., 1981). Ovariectomy results in 
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reduced total daily activity and lengthened free-running period (tau) and estradiol 
replacement to ovariectomized animals shortens tau in female rats (Albers, 1981), 
hamsters (Morin et al., 1977), and degus (Labyak and Lee, 1995). 
While the role of estradiol regulation of circadian rhythms in females has been 
researched, its function with respect to rhythms in males is less clear. Testosterone is the 
primary gonadal hormone in males and is converted to estradiol and dihydrotestosterone 
(DHT). Gonadectomy of male mice decreases total wheel-running activity, changes the 
distribution of activity across the day, and increases tau (Daan et al., 1975). Testosterone 
replacement restores activity and decreases free-running period to that of intact animals. 
Interestingly, DHT replacement also results in a partial restoration of activity 
(Karatsoreos et al., 2007), indicating that biological rhythms are regulated by both 
androgenic and estrogenic actions, at least in males.  
The actions of estrogens are primarily mediated through two distinct nuclear 
receptors: estrogen receptor 1 (ESR1, also known as estrogen receptor alpha) and 
estrogen receptor 2 (ESR2, also known as estrogen receptor beta). To exert action via 
nuclear receptor-mediated transcriptional activation, estrogens bind to nuclear receptors, 
which undergo a conformational change promoting dimerization. The hormone-receptor 
dimer then binds to the estrogen response element (ERE) on regulatory regions of target 
genes to alter gene transcription. In addition to these “classical” nuclear receptor-
mediated mechanisms, there are more recently characterized “non-classical” pathways 
(Hall et al., 2001, Kousteni et al., 2001). These alternative pathways include the action of 
the hormone-receptor dimer on non-ERE transcription factors, membrane estrogen 
receptor-initiated action via protein kinases, and ligand-independent ER signaling via 
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second messenger pathways (McDevitt et al., 2008). 
Previous studies in this and other labs have shown that a lack of estrogens, in 
gonadectomized animals and in transgenic models, influences the expression of circadian 
rhythms compared with control animals with endogenous estradiol. Aromatase knock-out 
mice are unable to synthesize estradiol and show increased activity during the light phase, 
decreased overall activity levels, and increased free-running periods relative to wild-type 
littermates (Brockman et al., 2011). While these data provide evidence for a role of 
estrogens in the regulation of circadian patterns, the underlying mechanisms of their 
action remain relatively unknown. Estrogen receptor knock-out models indicate that total 
daily activity level is regulated largely via estrogenic action at ESR1, but other circadian 
parameters have not been examined (Ogawa et al., 2003). To better characterize the 
interaction of estrogens and daily and circadian rhythmicity, we are using two transgenic 
mouse models with alterations in estrogen responsiveness at different points in their 
response pathway: ESR1 knock-out (ERKO) and “non-classical” estrogen receptor 
knock-in (NERKI) mice. ERKO mice cannot respond to estrogen via ESR1, but retain the 
ability to respond at ESR2. NERKI mice have a modified ESR1 receptor knocked into 
their genome that has a mutation in the ERE-binding domain. In NERKI mice therefore, 
estradiol action via ERE-mediated transcription is eliminated, but estrogens can still 
produce effects via other transcriptional pathways (Jakacka et al., 2002). NERKI mice 
maintain intact ESR2 signaling. This transgenic model allows us to explore effects of 
estrogens on rhythms that are not mediated by ERE-DNA binding via ESR1. 
These transgenic mice provide insight into the mechanism of estrogenic 
organization of circadian rhythms that differs from gonadectomized mice because they 
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retain circulating gonadally-produced steroid hormones yet have specific mutations in 
signaling pathways. Further, these mice are uniquely suited for discerning how estrogenic 
actions at ESR1 organize the expression of circadian rhythms across hormone-sensitive 
periods of development, rather than an acute disruption with ovariectomy/gonadectomy 
or estrogen antagonist administration. We will test the hypothesis that estrogens modify 
the expression of daily and circadian rhythms via ESR1 and via “non-classical” estrogen 
mechanisms by analyzing male and female WT, NERKI, and ERKO mice. We are 
interested in identifying the mechanisms underlying the expression of sex differences 
under normal physiological conditions thus we used gonadally intact animals throughout 
these studies. 
 
Methods: 
Animal Breeding and Care 
 Breeding colonies of ERKO and NERKI mice were created as described in 
Lubahn et al. and Jakacka et al., (2002) respectively. ERKO mice were a kind gift from 
Dr. Pierre Chambon (IGBMC, France) and NERKI mice were a kind gift from Dr. Larry 
Jameson (University of Pennsylvania, Philadelphia, PA). A total of 65 adult (4-7 months) 
NERKI, ERKO, and wildtype (WT) male and female littermates were used for these 
experiments and all mice were obtained from a breeding colony established at the 
University of Illinois. ERKO mice were obtained by mating males and females 
heterozygous for the mutation. NERKI mice were obtained from breeding heterozygous 
males with females heterozygous for the ERKO mutation as NERKI females are infertile. 
The non-classical estrogen receptor knock-in is thus on an ESR1 knock-out background. 
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All genotypes were confirmed using PCR. Control animals are WT littermates of NERKI 
and ERKO mice. 
Circulating hormone concentrations in ERKO, NERKI, and WT mice are 
relatively similar to one another, allowing us to compare between intact animals. 
Concentrations of follicle stimulating hormone and luteinizing hormone in WT mice do 
not differ from ERKO (Eddy et al., 1996) and NERKI (Jakacka et al., 2002) mice. 
Relative to WT mice, circulating concentrations of estradiol are not significantly different 
in NERKI males or females (Jakacka et al., 2002). In female ERKO mice, circulating 
estradiol concentrations are increased compared to WT females (Couse et al., 1995) and 
in ERKO males testosterone levels are slightly elevated relative to WT males (Eddy et 
al., 1996). 
Breeding animals and litters were maintained on Teklad 8626 rodent diet. Prior to 
activity monitoring adults were given a Teklad 2016 diet, which contains low soy 
estrogens (isoflavones) in the range of non-detectable to 20 mg/kg, and remained on this 
diet for the remainder of the studies. They were given food and water ad libitum. Estrous 
cycles of all adult females were confirmed via vaginal cytology for two weeks prior to 
behavioral experiments. Additionally, a visual scan of activity records did not indicate an 
effect of estrous stage on wheel-running or phase.  
 All animal procedures were approved by the Institutional Animal Care and Use 
Committee of the University of Illinois and were conducted in accordance with the NIH 
Guide for the Care and Use of Laboratory Animals. 
 
Determination of Daily Activity Patterns and Circadian Parameters 
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Mice were individually housed in plastic cages (28 x 16 x 12 cm) equipped with a 
metal wheel affixed to the top of the cage. Mice were maintained in 12 hour light : 12 
hour dark (LD) cycle unless otherwise indicated. The light intensity in the cages ranged 
from 220-360 lux (average 290 lux). Wheel revolutions were registered by a magnetic 
switch and recorded in 10-minute bins of activity that were recorded using VitalView and 
visualized by ActiView (Mini Mitter, Bend, OR). A 10-min bin was defined as active if 
the number of wheel-revolutions was equal to at least 10% of the animal’s peak daily 
activity rate (in wheel revolutions/10-min bin). The following variables were quantified: 
average daily wheel revolutions, light:dark ratio of activity (LD ratio), phase angle of 
activity onset relative to lights-off, duration of free-running period (tau), and length of 
active phase (alpha) in constant light (LL) and constant dark (DD) conditions. For all 
parameters in 12:12 LD entrainment (activity distribution, total activity, LD ratio, and 
phase angle) measures were calculated from at least 5 consecutive days.  
Temporal distribution of daily activity was determined by the number of wheel 
revolutions recorded in each 10-minute bin over a 24-hour time period and averaged 
across five days for each animal. These data were then averaged across each group to 
map the daily activity trends of WT, NERKI, and ERKO males and females. The total 
daily wheel revolutions for each animal was calculated based on five consecutive days in 
12:12 LD. These averages were then used to calculate the group averages for each 
genotype and sex.  
The LD ratio represents the activity during the light phase compared with the dark 
phase. LD ratios were averaged for 5 days for each individual animal, and then these 
values were averaged to determine the LD ratio for each group. A ratio close to 1.0 
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represents an animal that is almost exclusively active during lights-on, while a ratio close 
to 0 represents an exclusively nocturnal animal. 
The phase angle of activity onset is measured relative to the time of lights-off. 
Negative values indicate that the animal began wheel-running before lights-off, positive 
values indicate that the activity onset began after lights-off. The onset of the daily activity 
bout was defined as the first of three consecutive 10-minute bins of activity that were not 
separated by more than two 10-minute bins of inactivity before the next recorded active 
bout. 
The free-running period (tau) was recorded in both LL and DD conditions for at 
least 7 days. Data from the first 3 days in constant conditions were disregarded to avoid 
transition effects. The tau value was obtained from a periodogram analysis of wheel-
running activity using ActiView. The duration of the period of sustained activity during 
constant conditions (alpha) was calculated from 7 days of consecutive activity and 
averaged for each animal. Activity duration was measured from the onset of the daily 
activity bout to its cessation. Onset of activity was defined as above for phase angle. 
Activity cessation was defined as the last active bin in a period of consecutive activity of 
least 40 min that preceded at least two hours with no sustained activity. 
 
Statistical Analysis 
 Total daily activity, LD ratio, phase angle of activity onset, and tau and alpha in 
constant conditions were analyzed with a 2-factor ANOVA using sex and genotype as 
independent factors (SYSTAT). A priori post hoc comparisons were performed to 
determine differences between groups within a sex or within a genotype. The variation in 
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LD ratio and phase angle was quite large, so non-parametric tests were performed to test 
for effect size (Cohen, 1988). This test compares the magnitude of the difference between 
means independent of the sample size. An effect size of 0.2, 0.5, and 0.8 are small, 
medium, and large, respectively. To statistically compare wheel-running activity during 
the dark phase, we performed an ANOVA with genotype and time as the independent 
factors and mean wheel revolutions at two-hour intervals as the dependent variable. We 
compared males and females separately, and then used a priori post hoc analyses to 
compare between groups at a given time point. Lights-off was at Zeitgeber Time (ZT) 12 
(ZT0=lights-on) and activity was compared at ZT13, ZT15, ZT17, ZT19, ZT21, and 
ZT23. Differences were significant when p < 0.05.  
 
Results: 
Sex differences in daily activity patterns are modified by responsiveness to estrogens 
Daily Activity Patterns and Total Wheel-running Activity  
 The distribution of wheel-running activity across the day depended on sex and 
genotype. At the time of lights-off, all groups showed an initial surge of activity followed 
by a decline in wheel-running levels as the dark phase progressed (Figure 3). To further 
analyze the temporal pattern of activity we compared mean activity at two-hour intervals 
during the dark phase. Within females, there was a significant effect of genotype 
[F(2)=23.72, p<0.001] and time [F(5)=10.784, p<0.001] on activity, but no interaction. 
All females had increased activity at the beginning of the dark phase and there were no 
significant differences in activity level at ZT13 between WT, NERKI, and ERKO 
genotypes. However, as the dark phase progressed, differences in activity levels emerged. 
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ERKO females had significantly less activity than did WT females throughout the night 
(ZT 15, 17, 19, 21, p<0.05 for all comparisons). NERKI females had intermediate 
activity levels that were between WT and ERKO animals. They did not differ from 
ERKO females at any point in the dark phase and were less active than WT females at 
ZT17 (p<0.05) and ZT19 (p<0.05) only. At the end of the dark phase, one hour prior to 
lights-on (ZT23), activity levels among all genotypes were the same. 
Like females, the activity level for males increased dramatically following lights-
off (ZT13) then decreased across the night. There was a significant effect of genotype 
[F(2)=3.721, p=0.026] and time [F(5)=13.248, p<0.001] on activity, but no interaction 
between these variables. Unlike females, there were no significant differences in activity 
level between WT and either ERKO or NERKI males except at ZT19. At ZT19 ERKO 
males were less active than WT males (p<0.05). At ZT23, one hour prior to lights-on, 
NERKI males were less active than both WT (p<0.05) and ERKO males (p<0.05).  
WT females and males both had peak activity following lights off, with no 
significant difference in wheel-running at the beginning of the night at ZT13. However, 
WT animals exhibited a sex difference in activity level throughout the dark phase. The 
activity of WT males was significantly reduced compared to WT females at ZT15, ZT17, 
ZT19, and ZT21 (p<0.05 at all times). This sex difference in activity levels was not seen 
in ERKO or NERKI animals at any time point in the dark phase. 
We also compared total daily wheel-running activity in all groups. We found a 
significant effect of genotype on total activity [F(2)=7.365, p=0.001] but no effect of sex 
or an interaction between sex and genotype. Among females, WT animals were 
significantly more active than both NERKI (p<0.01) and ERKO females (p<0.01) (Figure 
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4). In contrast, among males, there was no significant effect of genotype. We also wanted 
to identify sex differences and post hoc analysis within a genotype revealed WT females 
were significantly more active than WT males (26,995± 2,047 and 18,945±1,689 total 
wheel revolutions respectively, p<0.05). This sex difference in total wheel-running 
activity was abolished in the NERKI and ERKO animals. 
 
The ability to respond to estrogen influences daily patterns of activity in LD 
LD ratio depends on genotype 
To compare the distribution of activity across the day we looked at the LD ratio, 
which describes the amount of activity during the light phase relative to the dark phase of 
the LD cycle. A greater LD ratio reflects more daytime activity. An ANOVA test 
identified a significant effect of genotype on LD ratio [F(2)=3.422, p=0.04] (Figure 5). 
There was no effect of sex or an interaction between sex and genotype on LD ratio. WT 
males were significantly more nocturnal (0.035±0.011) than ERKO males (0.12±0.022, 
p<0.05). The NERKI genotype somewhat restores the distribution of activity to the dark 
phase as the LD ratio of NERKI males (0.075±0.026) is intermediate to WT and ERKO 
males. The activity patterns in females differed from males, as we found no significant 
effect of genotype on LD ratio using parametric statistics. However, effect size analysis, 
which compares the magnitude of the difference independent of sample size, indicates 
that these groups have a large effect size between WT and both NERKI (d=0.85) and 
ERKO (d=0.82) females.  
Similar to our results for daily wheel-running amount, we found a sex difference 
in LD ratio in WT animals that was absent in NERKI and ERKO genotypes. WT females 
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(LD ratio= 0.014±0.004) were significantly more nocturnal than WT males (LD ratio= 
0.035±0.011, p<0.05). 
 
Phase Angle of activity is affected by genotype 
The time when animals begin their period of daily activity relative to the time of 
lights-off is described as the phase angle. Similar to LD ratio and total activity, we found 
a significant influence of genotype on phase angle [F(2)=5.183, p=0.009] but no 
influence of sex or interaction between sex and genotype. Within males, post hoc 
hypothesis testing indicated that WT animals had an activity onset closer to lights-off 
than that of ERKO mice (9± 1.3 min vs. 17± 2.6 min after lights-off; p=0.011). NERKI 
males began their daily activity relatively later than WT and ERKO males (27±6.9 min 
after lights-off), but there are no statistically significant differences between NERKI and 
either WT or ERKO males (Figure 6). Non-parametric effect size analyses indicate that 
these groups have a large effect size (d=1.44 for NERKI compared to WT males; d=0.94 
for NERKI compared to ERKO males). Among females, the effect of genotype on phase 
angle resembled that of their male littermates, with NERKI mice beginning activity later 
than WT and ERKO mice, however, there are no statistically significant differences 
between groups. Post hoc analysis did not detect any sex differences within any 
genotype. 
 
Circadian rhythms in constant conditions are sex-dependent 
Duration of the free-running period, tau, depends on sex 
In constant darkness the duration of the free-running period, tau, is significantly 
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affected by sex (ANOVA test, [F(1)=5.955, p=0.018]). There was no significant effect of 
genotype or an interaction between genotype and sex on tau in DD. Post hoc hypothesis 
testing showed that the free-running period of NERKI males (23.9 ± 0.04 hours) was 
significantly greater than that of WT males (23.7 ± 0.04 hours, p=0.04) and NERKI 
females (23.7 ± 0.04 hours, p=0.039) (Figure 7). There were no significant genotype 
differences among females, nor any sex differences between male and female WT or 
ERKO mice.  
For all groups the free-running period for animals housed in constant light was 
significantly lengthened when compared to tau in DD (p<0.05 for all comparisons). For 
all groups, free-running rhythms had a period less than 24 hours in DD, and greater than 
24 hours in constant light (LL). As was seen in DD, in LL the free-running period 
depended on sex (ANOVA test, [F(1)=2.602, p<0.001]). We did not find a significant 
effect of genotype or an interaction between sex and genotype. In contrast to data in DD, 
in LL, post hoc analyses show significant sex differences in tau between males and 
females for WT (p<0.05), NERKI (p<0.05) and ERKO (p<0.05) animals. In each case, 
females had a longer free-running period than did males. Within a sex, there was no 
effect of genotype on the free-running period in LL. 
 
Duration of daily activity in constant conditions; alpha 
We calculated duration of activity, described as alpha, for animals housed in DD. 
We found a significant influence of genotype [F(2)=3.721, p=0.03] (Figure 8), but no 
effect of sex or an interaction of sex and genotype on alpha. Among females, WT mice 
had a shorter alpha relative to ERKO mice (p<0.05). In contrast, among males, there were 
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no significant genotype differences. NERKI males tended to have an increased alpha 
relative to WT males, but this was not significant (p=0.08). We did not detect any sex 
differences within any genotype. 
In LL, an ANOVA test identified a significant influence of sex on alpha 
[F(1)=6.53, p=0.014] but no effect of genotype or an interaction between these variables. 
Among males, ERKO mice had a lengthened alpha duration relative to NERKI mice 
(p=0.042). There were no significant genotype differences among females. There was a 
significant sex difference in activity duration between WT males and females (p=0.013) 
that was absent in NERKI and ERKO genotypes. 
 
Discussion: 
We tested the hypothesis that estradiol modifies daily and circadian rhythms via 
its actions on ESR1 and non-classical signaling pathways. We examined activity 
parameters in intact animals, as we wanted to understand the mechanisms underlying sex 
differences in rhythms under physiological conditions as well as identify functional 
consequences of disrupted estrogenic response on activity patterns. We found significant 
sex differences in total activity, LD ratio, and activity levels during the dark phase of the 
day in WT animals that are abolished in the NERKI and ERKO genotypes. Our data also 
indicate that impairments in estrogenic signaling pathways result in changes in the 
distribution of activity during LD and constant conditions. Lastly, data from NERKI 
animals reveal a novel contribution of non-ERE mediated transcription and estrogen-
activated second messenger signaling pathways on LD ratio, and activity levels during 
the dark phase. Our data suggest that total daily activity is ESR1-dependent and daily 
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activity patterns (distribution of activity across the day, LD ratio, and alpha) are 
modulated by both classical and non-classical actions at ESR1. These results provide 
insight to the mechanisms that underlie sex differences in the hormonal regulation of 
daily and circadian rhythms.   
The most striking effects of altered estrogenic signaling were observed in the 
distribution and amount of daily wheel-running activity. Compared to males, WT females 
had sustained and elevated activity across the day (Figure 3), had more daily activity 
(Figure 4), and were more nocturnal (Figure 5). Ogawa et al., described total locomotor 
activity as dependent on ESR1 in both male and female animals, but did not find sex 
differences in total wheel-running activity in WT mice (Ogawa et al., 2003). In that study 
gonadectomized animals were treated with oil or estradiol. We find sex differences in 
total activity that may be present in intact animals only. Both NERKI and ERKO females 
have decreased wheel-running activity relative to WT females.  These data support the 
hypothesis that total wheel-running activity is regulated through ERE-mediated actions at 
ESR1 and provides evidence that there is no contribution from non-classical pathways. 
Both NERKI and ERKO females have increased LD ratios relative to WT animals. 
However, NERKI males had an intermediate LD ratio relative to WT and ERKO males. 
This suggests that there is a sex specific contribution of non-classical signaling pathways 
on activity patterns.  
Among females, there were significant differences in activity levels between 
ERKO and WT animals throughout the dark phase. In this measure, NERKI females 
appeared to have intermediate activity as they did not differ from ERKO or WT females 
at most of the time points examined. This provides evidence that non-classical signaling, 
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independent of ERE-mediated transcription, contributes to activity distribution in 
females. Identifying how the independent but related estrogen signaling pathways 
mediate activity patterns and amplitude, and whether there are sex differences in these 
mechanisms will provide a foundation for understanding sleep disturbances in humans.  
We measured the duration of tau in constant dark and light conditions. In other 
species, there is an effect of estradiol on the free-running rhythm when animals are 
housed in constant darkness; ovariectomized female hamsters have a lengthening of tau 
and administration of estradiol shortens this free-running period (Morin et al., 1977). We 
predicted that ERKO females, which cannot respond to circulating estradiol via ESR1, 
would be similar to ovariectomized rodents and thus have a longer tau in DD than WT 
animals. In DD and LL, however, we did not detect any significant differences in tau 
among females. It is possible that tau is not modified by developmental exposure to 
estradiol, as our transgenic mice show no significant differences regardless of their ability 
to respond to estrogen. In DD we found a sex difference between NERKI males and 
females and in LL there were sex differences in tau in all genotypes. Circulating 
hormones, and the ability to respond to the activational effects of these hormones, may 
have a larger modulatory role on the free-running period than exposure to hormones 
during developmental periods.   
Our data indicate that the contributions of non-ERE mediated transcription and 
estrogenic regulation of second messenger pathways may not always be additive with the 
classical pathways. For example, in males, we saw an “over-compensation” in the phase 
angle of activity onset and the period of the free-running rhythm in DD (Figure 6 and 
Figure 7).  These effects may be due to compensatory mechanisms in the animal as a 
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result of the impaired ESR1 signaling and also indicate that non-classical signaling 
pathways can modify the expression of circadian rhythms.   
The differences in the expression of circadian activity patterns in adulthood may 
be due, in part, to a role of estrogens in the regulation of response to photic cues. 
Estrogens may strengthen the coupling between endogenous behavioral rhythms and the 
external light environment, as we see more pronounced genotype differences in 
entrainment (LD) than in free-running conditions. In mammals, the suprachiasmatic 
nucleus (SCN) of the hypothalamus generates circadian rhythms in activity and estrous 
cyclicity and entrains activity to the LD cues (Stephan and Nunez, 1977). In addition to 
the ability to respond to light, the SCN is also regulated by internal cues, such as 
hormonal secretion. The influence of gonadal hormones on daily rhythms may be 
mediated by acting both centrally on the SCN and peripherally on downstream targets. In 
humans, there are estrogen receptors (ESR1 and ESR2) in the SCN, with significantly 
greater ESR1 expression in females relative to males (Kruijver and Swaab, 2002). The 
distribution of estrogen receptors in the mouse brain is less clear, though there is 
evidence for both ESR1 and ESR2 in the SCN with ESR2 being relatively more abundant 
(Shughrue, 1998, Mitra et al., 2003, Vida et al., 2008). The function of these SCN 
estrogen receptors remains unknown, although it has been hypothesized that they may not 
play a major role due to their relatively low expression levels (Karatsoreos et al., 2007).  
It is probable that estrogens modify behavioral patterns by acting on a number of targets 
including those downstream from the SCN.  
We have identified sex differences in daily and circadian activity patterns and 
characterized how these differences are modified by the ability to respond to estrogens at 
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ESR1. This initial study sets the foundation for future work, which will identify the 
contribution of organizational and activational hormone effects on the expression of 
rhythmic patterns. ERKO and NERKI mice are useful for identifying the organizational 
role of hormones on circadian rhythms, as these animals have had an impaired ability to 
respond to endogenous estrogen over their lifespan, and they shed light on the estrogenic 
mediation of sex differences in circadian behaviors. Future studies will determine if there 
is a functional consequence of estrogen signaling impairment on the ability to entrain to 
the LD cycle or respond to circadian disruptions. 
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Figure 3: Relative patterns of daily activity for WT, NERKI, and ERKO mice grouped 
by sex. Average daily wheel-running activity (±SEM) was measured in 12:12 light dark 
cycle (lights-off at ZT 12) for 5 consecutive days. The number of wheel revolutions was 
averaged into 1-hour bins. Activity levels during the dark phase were compared and 
differences between groups are indicated: * WT vs. ERKO (p<0.05), # WT vs. NERKI 
(p<0.05), and + NERKI vs. ERKO. Sample sizes are as follows: for female WT (n=15), 
NERKI (n=7), and ERKO (n=8) and male WT (n=7), NERKI (n=6) and ERKO (n=19). 
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Figure 4: Average total wheel revolutions ± SEM for male and female WT, NERKI, and 
ERKO mice. Data were averaged over 7 days during a 12:12 light:dark cycle. WT 
females had significantly greater activity than both NERKI (* p<0.05) and ERKO 
(*p<0.05) animals. Among WT mice, females had significantly greater activity than 
males (a compared to b, p<0.05). Sample sizes as follows: for female WT (n=15), 
NERKI (n=7), and ERKO (n=8) and male WT (n=7), NERKI (n=6) and ERKO (n=19). 
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Figure 5: Average LD ratio ± SEM for female and male WT, NERKI, and ERKO mice 
housed in 12:12 light:dark cycle. Among WT mice, female activity was more 
consolidated to the dark phase than males (a compared to b, p<0.05). Among males, the 
LD ratio of WT mice is less than that of ERKO mice (*p<0.05). Sample sizes as follows: 
for female WT (n=15), NERKI (n=7), and ERKO (n=8) and male WT (n=7), NERKI 
(n=6) and ERKO (n=19). 
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Figure 6: Average onset of activity relative to lights-off, phase angle (min) ± SEM for 
animals housed in 12:12 light:dark cycle for 5 days. WT males begin activity closer to 
lights-off than ERKO males (* p<0.05). Sample sizes as follows: for female WT (n=15), 
NERKI (n=7), and ERKO (n=8) and male WT (n=7), NERKI (n=6) and ERKO (n=19). 
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Figure 7: Average tau ± SEM for animals housed in constant dark (a) or constant light 
(b). LL and DD y-axis values differ. Values were determined from 7 days of activity. In 
DD: WT males had a shorter tau than NERKI males (* p<0.05). NERKI females had a 
shorter tau than NERKI males (a compared to b, p<0.05). Sample sizes as follows: for 
female WT (n=15), NERKI (n=8), and ERKO (n=8) and male WT (n=7), NERKI (n=6) 
and ERKO (n=19). In LL: For each genotype, there is a significant sex differences (*,+,# 
p<0.05). Sample sizes as follows: for female WT (n=13), NERKI (n=9), and ERKO 
(n=9) and male WT (n=7), NERKI (n=6) and ERKO (n=19). 
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Figure 8: Average duration of the active period (alpha) ± SEM for animals housed in 
constant dark (DD) conditions (a) or constant light (b) for 7 days. In DD: ERKO females 
had an increased duration of activity relative to WT females (* p<0.05). Sample sizes as 
follows: for female WT (n=15), NERKI (n=8), and ERKO (n=9) and male WT (n=7), 
NERKI (n=6) and ERKO (n=12). In LL: ERKO males had an increased duration of 
activity relative to NERKI males (* p<0.05). Sample sizes as follows: for female WT 
(n=11), NERKI (n=7), and ERKO (n=8) and male WT (n=7), NERKI (n=5) and ERKO 
(n=15). 
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CHAPTER 2 
 
Phase response curve and cellular activation in response to light-pulse in the 
suprachiasmatic nucleus of two strains of mice with impaired responsiveness to estrogen 
 
 
 
Abstract: 
There are sex differences in the expression of daily activity and circadian rhythms, including free 
running period, phase angle of activity onset, and photic phase response curve, yet the 
mechanisms underlying these effects are not fully understood. We tested the hypothesis that 
estrogen signaling is required for photic responsiveness of the circadian timing system. We 
utilized estrogen receptor subtype 1 (ERS1) knock-out mice (ERKO) and non-classic estrogen 
receptor knock-in mice (NERKI). ERKO animals are unable to respond to estrogen at ESR1, but 
still produce estradiol and have active estrogen receptor subtype 2. NERKI animals lack the 
ability to respond to estrogens via estrogen response element-mediated transcription, but still 
respond via non-classical mechanisms. We analyzed behavioral shifts in activity onset in 
response to 1 hr light pulses given across the subjective day in intact male and female wildtype 
(WT), NERKI, and ERKO mice. We also examined light induced Fos protein expression in the 
suprachiasmatic nucleus, the site of the master circadian pacemaker. We found a significant 
effect of sex and genotype on phase shifts in response to light pulses given in the subjective 
night. Males shifted an average of 47 min less than did females (p<0.05) at Zeitgeber time (ZT) 
16 (ZT 0 lights-on and ZT 12 lights-off). Among females, WT animals have a significantly 
larger phase response than ERKO animals at ZT 16 (phase shift of 98 min and 58 min, 
respectively; p<0.05). This genotype effect is not observed in males at the same time point, 
suggesting a sex-specific effect of estrogen influence on light response. These data will 
contribute to identifying the mechanisms underlying sex differences in activity patterns and 
circadian rhythms. 
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Introduction: 
There are sex differences in the mechanisms by which the endogenous pacemaker 
entrains to exogenous light-dark cycles, the duration of the free-running period, and the level and 
distribution of daily activity (Gentry and Wade, 1976, Davis et al., 1983, Iwahana et al., 2008, 
Brockman et al., 2011). These sex differences are attributed, at least in part, to the action of 
gonadal hormones. Estradiol and testosterone have modulatory roles on the expression of the 
level of activity, the distribution of activity across the light-dark cycle, and the period of free-
running activity. Estradiol replacement to ovariectomized rats, hamsters, and degus advances the 
onset of the daily activity bout and increases the level of total activity relative to non-treated 
controls (Gentry and Wade, 1976, Morin et al., 1977, Albers, 1981, Labyak and Lee, 1995). 
Treatment with testosterone restores activity levels and distribution in gonadectomized male 
mice (Iwahana et al., 2008).  
Previous studies in this and other labs have indicated a role of estrogens in the 
modulation of circadian rhythms. Estradiol replacement shortens free-running rhythms in 
ovariectomized female rats (Albers, 1981) and hamsters (Morin et al., 1977). The presence of 
circulating gonadal hormones influences the behavioral phase response curve for male and 
female mice (Daan and Pittendrigh, 1976) and degus (Jechura, 2000). In addition to the acute 
removal of circulating gonadal hormones via gonadectomy, impairment in the ability to produce 
or respond to estrogens also influences the expression of circadian rhythms and activity. 
Aromatase knock-out mice, that cannot produce endogenous estradiol, show decreased daily 
wheel-running activity, increased fragmentation of activity, and altered phase shifts in response 
to light pulses relative to wildtype (WT) counterparts (Brockman, 2011).  
While these data indicate estrogens modulate daily and circadian rhythms and overall 
activity, the mechanisms of this estrogenic modulation remain unknown. Estrogens acting at 
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estrogen receptor subtype 1 (ESR1, or estrogen receptor alpha) regulate the amount of total 
locomotor activity; ESR1 knock-out mice have decreased total daily wheel-running activity 
relative to WT counterparts (Ogawa et al., 2003). Unpublished data from our lab indicate that 
mice with impaired response to estrogenic action at ESR1 have decreased total wheel-running 
activity and increased daytime activity relative to wildtype mice. The differences in behavior in 
entrainment conditions may indicate a role of estrogens in modifying the response to light, or 
how an animal matches its own behavior to the environmental light cues. 
The photic phase response curve describes a behavioral or neuronal response to a light 
cue given at different times throughout the subjective light and dark period. Typically, animals 
that are given a light pulse during the early subjective night have a phase delay in their activity 
rhythm, while light pulses during the late subjective night advance rhythms (Daan and 
Pittendrigh, 1976). Light pulses during the subjective day have little effect on the phase of 
activity. The central oscillator, the suprachiasmatic nucleus (SCN), maintains intrinsic circadian 
rhythms in behavior (Nunez and Stephan, 1977, Stephan and Nunez, 1977). Photic information 
reaches the SCN and the responsiveness can be measured by the expression of Fos, a member of 
the immediate early gene family. In addition to its light induction, estrogens also influence Fos 
expression in the SCN (Peterfi et al., 2004).   
Estrogenic action is mediated through at least two distinct nuclear receptors: ESR1 and 
estrogen receptor subtype 2 (ESR2, or estrogen receptor beta) as well as more recently 
characterized “non-classical” pathways including membrane-associated estrogen receptors, (Hall 
et al., 2001, Kousteni et al., 2001). In nuclear receptor-mediated transcriptional activation, 
estrogens bind to receptors, and the ligand-receptor complex forms a dimer that binds 
transcription factors. In this “classical” pathway, the hormone-receptor dimer binds to the 
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estrogen response element (ERE) on regulatory regions of target genes to alter gene 
transcription. Additionally, there are other “non-classical” mechanisms of estrogen signaling, 
which include estrogenic action at non-ERE transcription factors, membrane-initiated action via 
protein kinases, and ligand-independent estrogenic signaling via second messenger pathways 
(McDevitt et al., 2008).  
To better understand how steroids influence the response of circadian rhythms to light, 
we characterized the interaction of estrogens and response to light pulse using two transgenic 
mouse models with impairments in responsiveness to circulating estrogens. ESR1 knock-out 
(ERKO) mice cannot respond to estrogens via ESR1, but retain the ability to respond at ESR2. In 
“non-classical” estrogen receptor knock-in (NERKI) mice, a modified ESR1 receptor with a 
mutation in the ERE-binding domain is inserted (Jakacka et al., 2002). In these mice, estrogenic 
action via ERE-mediated transcription is eliminated, but estrogens retain the ability to act via 
other transcriptional pathways as well as at intact ESR2. The NERKI model allows us to explore 
effects of estrogens on behaviors that are not mediated by ERE-DNA binding. The phase 
response curve reflects how the circadian time-keeping system entrains the endogenous rhythm 
to external cues. We will test the hypothesis that the ability to respond to estrogens, specifically 
at ESR1, influences this function by examining how impaired responsiveness to estrogens 
modifies the behavioral and neuronal response to light pulse. We are interested in identifying the 
mechanisms underlying the expression of sex differences under normal physiological conditions, 
thus we used gonadally intact animals throughout these studies. 
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Methods: 
Animal Breeding and Care 
 Adult intact (4-7 month old) NERKI (n=15), ERKO (n=27), and WT (n=21) male and 
female littermates were used for these experiments. All mice were obtained from a breeding 
colony established at the University of Illinois. ERKO mice (Dr. Pierre Chambon, IGBMC, 
France) were obtained by mating males and females heterozygous for the mutation. NERKI mice 
(Dr. J. Larry Jameson, University of Pennsylvania, Philadelphia, PA) were obtained by breeding 
heterozygous males containing one copy of the mutated ESR1 allele with females heterozygous 
for the ERKO mutation, as NERKI females are infertile. The non-classical estrogen receptor 
knock-in is thus on an ESR1 knock-out background. All genotypes were confirmed using PCR. 
Control mice are wildtype littermates of NERKI and ERKO mice. Food and water were given ad 
libitum. Breeding animals and litters were maintained on Teklad 8626 rodent diet. Prior to 
activity monitoring, animals were given Teklad 2016 diet, which contains low soy estrogens 
(isoflavones) in the range of non-detectable to 20 mg/kg, and remained on this diet for the 
remainder of the studies.  
 Mice were maintained in 12 hour light : 12 hour dark (LD) cycles unless otherwise 
indicated, and the light intensity in the cages ranged from 220-360 lux (average 290 lux). 
Animals were individually housed in cages (28 x 16 x 12cm) equipped with a metal wheel 
affixed to the top of the cage. Wheel revolutions were registered by a magnetic switch and 
recorded in 10-minute bins of activity. Wheel running activity was recorded and visualized using 
VitalView and ActiView (MinitMitter, Bend, OR). All animal procedures were approved by the 
Institutional Animal Care and Use Committee of the University of Illinois and were conducted in 
accordance with the NIH Guide for the Care and Use of Laboratory Animals. 
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In these studies, we compare gonadally intact animals. Circulating hormone 
concentrations for NERKI and ERKO animals have been previously reported. In intact female 
NERKI mice, the levels of follicle stimulating hormone (FSH), lutenizing hormone (LH), and 
estradiol are not significantly different when compared to wildtype littermates; progesterone 
levels are decreased in NERKI females (Jakacka et al., 2002). In intact ERKO males, 
testosterone levels are slightly elevated relative to wildtype mice, but there is no difference in 
FSH and LH levels (Eddy et al., 1996). In ERKO females, circulating serum levels of estradiol 
are increased compared to wildtype females (Couse et al., 1995).  
 
Determination of Phase Response to Light-Pulse 
 The behavioral shift in activity that results from a light-pulse given at different times of 
the subjective day is called a phase response. A modified Aschoff Type II procedure was used 
which enables us to pulse animals with light before their free-running rhythms drift significantly 
from their entrainment to the LD cycle. Animals were entrained to a 12:12 LD cycle then placed 
in constant darkness (DD) for at least 24 hours prior to a one-hour light-pulse. The light pulse 
was given at different times during their subjective day or night which correspond with the 
former Zeitgeber times (ZT) 0, 4, 8, 16, and 22 (ZT 0=lights-on, ZT 12=lights off). Following 
the light pulse, animals were returned to constant darkness for at least 7 days. Sample size for 
these behavioral tests was 6-14 for females and 5-18 for males. 
 The phase response, measured in minutes, was calculated as the difference between the 
pre-pulse and post-pulse regression lines on the day following the light pulse. The pre-pulse 
regression line was determined by the onset of activity for at least 3 days prior to the light-pulse. 
The post-pulse regression line was determined for 7 days in DD, disregarding the day 
 
   
!
50 
immediately following the light pulse to avoid transition effects. 
 
Cellular activation in the SCN 
 Mice (n=60) were entrained to 12:12 LD prior to going into DD for at least 24 hours. 
They were given a one-hour light-pulse at times corresponding to either ZT 4 or ZT 16, as 
described above. Animals were perfused immediately following the one-hour light-pulse (ZT 5 
or ZT 17, respectively). Brains were collected, stored overnight in a 4% paraformaldehyde 
solution, and then transferred to a 20% sucrose solution. Tissue was sectioned in 40 um slices in 
three series for analysis. 
 
Single label immunhistochemisty  
To detect c-Fos in the SCN, every third section of the SCN from each animal (WT, 
NERKI, and ERKO males and females pulsed at ZT 4 or ZT 16, n=3-5/group) was processed in 
parallel. Free-floating sections were incubated in rabbit polyclonal anti-c-Fos (sc-52) antibody 
(lot #G1108, 1: 20,000 dilution, Santa Cruz Biotechnologies) containing 0.3% Triton-X 
overnight at room temperature on a shaking platform. They were then incubated in biotinylated 
goat anti-rabbit antibody (1: 400 dilution, Vector Laboratories, Burlingame, CA) for 1.5 hours at 
room temperature. Finally, sections were incubated in peroxidase-conjugated avidin biotin 
complex following manufacturer’s directions (Vector Laboratories, Burlingame, CA) for 1.5 
hours at room temperature. The peroxidase reaction was carried out at room temperature in TRIS 
buffer (pH 7.6) containing one 10mg tab DAB in 50 mL TRIS buffer (0.0002% DAB) (Sigma-
Aldrich), and 0.0006% H2O2. Between each step, free-floating sections were rinsed in 0.01% 
PBS for 3 x 5 min. Sections were then mounted on gelatin-coated slides, air dried, dehydrated 
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through an ascending alcohol series, cleared in xylene, and cover-slipped with Permount 
mounting medium. 
 
Photomicrography and data analysis 
 For each group, the region containing the suprachiasmatic nucleus of the immuno-stained 
sections were photographed and the captured images were then analyzed with Image J software 
(available at http://rsb.info.nih.gov/ij/download/src/). The SCN was divided into core and shell 
(Yan and Silver, 2004). Cells were counted from both of the paired nuclei. 
 
Statistical Analysis 
 Behavioral shifts (min) were analyzed with two-factor ANOVA with sex and genotype as 
independent factors (SYSTAT). A priori post-hoc comparisons were then performed to 
determine sex differences within a genotype or genotype differences within a sex. Differences 
were considered significant when p < 0.05. The cellular response to light pulses was measured as 
the number of Fos-positive cells. This dependent variable was analyzed in two-factor ANOVA 
with time and genotype as independent factors; males and females were analyzed separately 
(SYSTAT). Within each time point (ZT 4 and ZT 16) a two-factor ANOVA was performed with 
sex and genotype as independent factors. A priori post-hoc comparisons were then performed to 
determine differences between experimental groups. Differences were significant when p < 0.05. 
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Results: 
Phase Response Curve: genotype influences phase response in females, but not males 
 Mice exposed to a 1-hour light pulse during constant darkness had phase shifts in wheel-
running activity dependent upon the time of the light pulse (Figures 9 and 10). The pattern of the 
phase response curve was typical of that of other species (Daan and Pittendrigh, 1976). Animals 
exhibited a phase delay in response to a light pulse given in the early subjective evening (ZT 16) 
and a phase advance in response to light pulses in the late subjective evening (ZT 22) and at the 
beginning of the subjective day (ZT 0). There were relatively small phase shifts in response to 
light pulses given during the subjective day, or inactive period (ZT 4 and ZT 8). 
 We observed sex differences and genotype differences in the magnitude of phase 
response to light pulse. ANOVA revealed an effect of sex on phase response to light pulse early 
in the subjective dark phase at ZT 12 [F(1,51)=31.665, p<0.001] and ZT 16 [F(1,51)=10.645, 
p=0.002]. At these times there was no effect of genotype or an interaction between sex and 
genotype. Late in the subjective dark phase (ZT 22) there was an interaction between sex and 
genotype [F(2,55)=3.542, p=0.036]. Just before subjective lights-on (ZT 0) there was an effect of 
sex on phase response [F(1,47)=4.197, p=0.046] and an interaction between genotype and sex 
[F(2,47)=4.923, p=0.011]. Light pulses during the subjective daytime (ZT 4 and ZT 8) did not 
show an effect of genotype, sex, or an interaction between genotype and sex. 
The phase response of WT and ERKO females differed early and late in the subjective 
night, and NERKI animals had intermediate phase responses to light pulses given at these times. 
Among females, there were significant behavioral differences between intact WT and ERKO 
mice in response to light pulses given early in the subjective evening (ZT 16; p=0.025), late in 
the subjective evening (ZT 22; p=0.021), and at the beginning of the subjective day (ZT 0; 
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p=0.025) (Figure 9). NERKI mice had an intermediate response and did not differ significantly 
from WT female or ERKO females at any time point. In WT females the magnitude of the 
behavioral response to a light pulse was significantly greater than ERKO females at ZT 16 
(phase delay of -98.2 ± 11.7 min, n=11 and -57.8 ± 11.2 min, n=9, respectively) and significantly 
less than ERKO females at ZT 22 (12.1 ± 4.7 min, n=14, and 38.6 ± 11.6 min, n=7, 
respectively). In the early morning (ZT 0) light pulse causes a moderate phase delay in ERKO 
females (-8.6 ± 4.6 min, n=7) and a slight phase advance in WT females (5.8 ± 3.6 min, n=12, 
p<0.05). Pulses during the subjective day (ZT 4 and ZT 8) did not produce significant 
differences in behavioral shifts between any group; in both WT and ERKO females, these light 
pulses produce minimal shifts in activity. Interestingly, the magnitude of phase response for 
ERKO females was significantly larger than WT females at ZT 22 and significantly less at ZT 
16. 
 In contrast to the differences found between female groups, males, regardless of 
genotype, did not differ with respect to their phase response. At all tested pulse times there were 
no significant differences between WT, NERKI, and ERKO genotypes for males (Figure 10).  
 There were sex differences in phase response to light pulse. At ZT 16, there was a 
significant difference between WT males and females, with females showing a significantly later 
phase delay (phase delay of -98.2 ± 11.7 min, n=11 in females and -51.4 ± 10.8 min, n=7 in 
males, p=0.015). In ERKO mice, the magnitude of the phase response was significantly different 
for males and females at ZT 0 (p=0.006) and ZT 4 (p=0.003). The sex differences observed in 
WT and ERKO mice were not seen in the NERKI genotype; there are no significant sex 
differences in the behavioral phase response to light pulse in NERKI animals at any of the time 
points measured. 
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Number of Fos reactive nuclei across the SCN depends on the time of light pulse. 
We analyzed the distribution and number of Fos-positive cells in the suprachiasmatic 
nucleus (SCN) subdivided into two regions, shell and core, and the total SCN (Figure 11). 
Within males, a two-factor ANOVA of total Fos expression showed a significant effect of time 
[F(1,16)=4.73, p=0.045] and genotype [F(2,16)=7.632, p=0.005] on the number of Fos-positive 
cells in total SCN, but no interaction between time and genotype. Among females, only time had 
a significant effect on the total number of Fos-positive cells [F(1,15)=6.948, p=0.045], but there 
was no significant effect of genotype or an interaction between these variables. At ZT 16 there is 
no significant effect of sex or genotype on Fos expression, however, there is a significant 
interaction between sex and genotype [F(2,15)=3.719, p=0.049]. We then performed post hoc t-
tests to determine differences between groups. Among WT males, the number of Fos-positive 
cells in the total SCN is increased in response to light pulse at ZT 16 relative to ZT 4 (p<0.05). 
At ZT 16 the Fos expression in WT males is significantly greater than in ERKO males (p<0.05). 
However, in NERKI and ERKO males there was no significant difference between the two time 
points. Among females there was a significant increase in Fos-positive cells in response to light 
pulse at ZT 16 relative to ZT 4 in ERKO mice only (p<0.05). There were no differences between 
times for WT or NERKI females. At ZT 16 only there was a significant sex difference in total 
Fos-positive cells in ERKO mice (p<0.05). 
Within the shell region, there is a significant effect of time of light pulse on number of 
Fos-positive cells for both males [F(1,16)=38.29, p<0.01] and females [F(1,17)=24.559, p<0.01] 
(Figure 12). For males only there was also an interaction between time and genotype 
[F(2,16)=7.223, p<0.01]  There was no significant effect of genotype on the number of Fos-
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positive cells in the shell for either sex. We also tested for effect of sex and genotype on Fos 
expression in the shell region at ZT 4 and ZT 16. At ZT 4 only, there is a significant effect of 
genotype [F(2,15)=4.302, p=0.033], but not sex, on Fos expression in the shell region. At ZT 4 
there is also an interaction between sex and genotype [F(2,15)=3.857, p=0.045]. Two sample 
post hoc t-tests were performed to isolate significant differences in Fos expression in the shell 
region between groups. Among WT males, Fos expression following light pulse is greater at ZT 
16 than ZT 4 (p<0.05). This is true for NERKI males (p<0.05), but not ERKO males. Among 
females, Fos expression following light pulse at ZT 4 is greater at than ZT 16 for WT (p<0.05) 
and ERKO (p<0.05), but not NERKI mice. There are no significant sex differences for any 
genotype at any time. Fos expression in the shell at ZT 4 is significantly lower for ERKO males 
relative to both WT (p<0.05) and NERKI (p<0.05) males. 
Finally, within the core region, there is an effect of time on Fos expression for males 
[F(1,16)=48.749, p<0.01] and females [F(1,15)=63.72, p<0.01] (Figure 13). Among males, but 
not females, there is an effect of genotype [F(2,16)=11.156, p<0.01] and an interaction between 
time and genotype [F(2,16)=7.331, p<0.01] for Fos expression in the core region. At time ZT 4 
there is an effect of sex on Fos expression in the core [F(1,16)=10.124, p<0.01] but not a 
significant effect of genotype or an interaction between sex and genotype. Following light pulse 
at ZT 16, conversely, there is a significant effect of genotype [F(2,15)=5.577, p=0.015] and an 
interaction between sex and genotype [F(2,15)=8.282, p<0.01], but no significant effect of sex 
on Fos expression in the core. Fos expression within the core region following light pulse at ZT 
16 is significantly greater than at ZT 4 for WT males (p<0.01) and NERKI males (p<0.01), but 
not ERKO males. For females, Fos expression within the core following light pulse at ZT 16 is 
significantly greater than at ZT 4 for WT females (p<0.01) and ERKO females (p<0.01), but not 
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NERKI females. There are sex differences in Fos expression in the core region only in ERKO 
animals following light pulse at ZT 16 (p<0.05). In females at ZT 4 and at ZT 16, there are no 
significant genotype differences in Fos expression in the core. In males, however, Fos expression 
in the core following light pulse at ZT 16 is significantly less in ERKO males than in WT males 
at the same time (p<0.05). 
 
Discussion:  
To better understand the role of estrogenic modulation of circadian response to light, we 
characterized the phase response curve in intact male and female NERKI and ERKO mice and 
their WT littermates. Our results indicate that the ability to respond to estrogens via ESR1 
influences the response to light pulse given during the subjective dark phase in females (Figure 
9), but not males (Figure 10). Secondly, the intermediate behavioral shifts in response to light 
pulse seen in NERKI females indicates a novel, “non-classical” estrogenic signaling mechanism 
that contributes to the function of the circadian system and response to light pulse. Lastly, 
immunohistochemical results suggest the location of the modification of these rhythms may be 
downstream from the SCN, as the genotype differences in Fos expression do not correspond to 
the behavioral shifts in activity (Figures 11-13). 
There are significant differences in the magnitude of the phase response to light pulse 
during the subjective night in female ERKO mice relative to WT littermates. ERKO females, that 
lacked the ability to respond to estrogens at ESR1 during development, show differences in the 
magnitude of their response to light pulse both early and late in the subjective dark phase relative 
to WT females. Previous studies have indicated a role for estrogens in the phase response to a 
light pulse. Ovariectomized female mice have a smaller phase shift in response to light at ZT 16 
than intact counterparts (Daan and Pittendrigh, 1976, Brockman et al., 2011). These studies 
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suggest that the mechanism of this estrogenic regulation of response to light is via estrogens 
binding to ESR1. We observed significant differences in response to light pulse during the 
subjective night (at ZT 16 and ZT 22) between WT and ERKO females, with the greater 
magnitude of the response at ZT 16 in the WT females. Ability to respond to circulating 
estrogens as ESR1 also influences the magnitude of the behavioral response to a light pulse 
given late in the subjective night (ZT 22), however at this time ERKO females respond with a 
greater phase delay than WT counterparts. 
In the absence of ESR1 action via ERE-dependent mechanisms, NERKI mice have an 
intermediate response between the ERKO and WT response at ZT 16 and ZT 22. The ERKO 
females demonstrate that estrogenic action at ESR1 mediates the behavioral response to light 
pulse, and the results from NERKI mice reveal a contribution by non-classical estrogenic 
mechanisms. The ability to respond to estrogen at ESR1 through both classical ERE-mediated 
transcription and non-classical pathways mediate normal response to light pulse.  
There are sex differences in the photic phase response curve of WT mice in that WT 
females have a greater phase delay at ZT 16 than WT males. The genotype differences between 
female WT, NERKI, and ERKO mice are not present in males, suggesting sex differences in how 
estrogens mediate the response to light pulse. Data from NERKI and ERKO mice contribute to 
our understanding of the mechanisms that mediate these sex differences. There is growing 
evidence that sex differences in circadian behaviors, including phase response curves, are 
modified by the presence of gonadal hormones (Gander and Lewis, 1983, Karatsoreos et al., 
2007, Brockman et al., 2011). In WT mice in this study, the behavioral response to light pulse 
early in the subjective dark phase was of greater magnitude in females than males. Further, while 
genotype influenced the phase response curve in females, intact WT, NERKI, and ERKO males 
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do not differ in response to light pulse given at any time of the subjective day or night. This may 
suggest sex-specific roles for estrogenic mediation of phase response to light, and that estrogens 
play a larger role in the organization of circadian rhythms in females than in males. Recent 
literature suggests that the hormonal mediation of circadian responses in males may be primarily 
through androgen action in the SCN (Karatsoreos et al., 2007, Iwahana et al., 2008). However, 
there is evidence in rats that the expression of Fos in the SCN in response to light pulse is 
mediated by estrogens (Abizaid et al., 2004, Peterfi et al., 2004). 
The patterns of Fos-activation in the SCN following light pulse given during the 
subjective night shed light on the neuronal mechanisms underlying the observed behavioral 
responses. In mammals, the SCN of the hypothalamus generates circadian rhythms (Stephan and 
Nunez, 1977). Cells in the SCN respond to photic stimuli via the retinohypothalamic tract. The 
SCN is responsible for the synchronization of endogenous circadian rhythms with cues from the 
external environment, the most pronounced of which is the daily light-dark cycle. The SCN has 
two anatomical regions that are functionally distinct: the core and the shell. The shell contains 
cells that are light-responsive, while the core contains cells that have intrinsically oscillating 
gene expression (Yan et al., 1999). These sub-regions communicate as the central clock resets 
itself following light pulses (Yan and Silver, 2004). We found a significant effect of time on total 
SCN Fos expression, and Fos expression in the shell and core regions among both males and 
females. A light pulse given during the subjective dark phase (ZT 16) increases Fos expression in 
the core region, where cells are intrinsically oscillating, relative to a light pulse given during the 
subjective day (ZT 4). The greater number of Fos-positive cells in the SCN core following a light 
pulse during the subjective night may reflect a re-setting of the circadian clock. Among males, 
that did not show behavioral differences in response to light pulse, there is a significant effect of 
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genotype on Fos expression in response to light pulse in total number of Fos-positive cells and 
within the core region. Further, among males, Fos expression following a light pulse in both shell 
and core regions have significant interactions between genotype and time. The lower expression 
of Fos in the core in response to a light pulse at ZT 16 in ERKO males relative to WT males may 
suggest that estrogenic action via ESR1 is involved in mediating this response to light pulse. 
Sex differences in behavior, coupled with evidence of sex differences in estrogen 
receptor expression in the SCN (Vida et al., 2008) led us to hypothesize that estrogens act in the 
SCN to modify sex differences in phase response to light pulse. Interestingly, we do not observe 
a significant effect of sex on light-induced Fos response at ZT 16, nor are there any statistically 
significant differences between sexes for WT or NERKI mice (ERKOs, however, do show 
significant sex differences in Fos expression in core and total SCN). Gonadal hormones may 
mediate the behavioral expression of daily rhythms by acting centrally on neurons in the SCN 
itself and also by binding receptors on downstream targets peripheral to the SCN. In the 
behavioral response to light pulse, there were significant differences among genotypes in 
females, but not males. However, there was no significant effect of genotype on Fos expression 
in the SCN. There are sex differences in the expression of estrogen receptors in the mouse SCN; 
in gonadectomized females about 4.5% of neurons in the SCN are positive for ESR1 relative to 
3% for gonadectomized males; treatment with estrogens does not increase expression of ESR1 in 
either sex (Vida et al., 2008). Both ESR1 and ESR2 are expressed to varying degrees in the 
mouse SCN (Shughrue, 1998) and there is greater expression of ESR2 relative to ESR1 (Mitra et 
al., 2003). Within the SCN, the expression of ESR1 is greater in the shell than the core (Vida et 
al., 2008). Likewise, in humans, there are estrogen receptors of both subtypes in the SCN, with 
significantly greater ESR1 expression in females relative to males (Kruijver and Swaab, 2002). It 
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is also possible that estrogens acting at receptors peripheral to the SCN regulate behavioral 
response to light pulse. For example, Ogawa et al., (2003) found increased wheel-running 
activity following estradiol implantation into the medial preoptic area of mice.  
In this study, we were interested in characterizing the photic and neuronal response to 
light pulse in intact animals, to identify sex-specific the behaviors of mice with circulating 
gonadal hormones and how specific disruptions in estrogenic signaling pathways mediate these 
behaviors. Our next steps will be to determine how estrogenic actions at ESR1 organize the 
expression of circadian rhythms over the lifespan, and following gonadectomy and estrogen 
administration. Intact NERKI and ERKO mice provide an opportunity to examine the estrogenic 
mediation of circadian behaviors to elucidate the mechanisms that underlie sex differences in 
circadian rhythms. These models may help to identify causal factors that underlie sex differences 
in human sleep and circadian rhythms and indicate potential therapeutic targets for sleep 
disorders (Duffy et al., 2011, Mong et al., 2011). Previous studies in this lab using NERKI and 
ERKO mice show significant sex and genotype differences in level and distribution of activity. 
Together, the behavioral and neuronal photic phase response data elucidate the mechanisms that 
underlie sex differences in estrogenic modification of behavioral and neuronal response to light 
pulse. 
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Figure 9: Photic phase response curve for female WT, NERKI, and ERKO mice (phase response 
(min) ± SEM). Animals were pulsed with light for one hour at ZT 0, 4, 8, 16, and 22, and the 
phase response in minutes was determined. Sample size as follows: WT (n=11-14), NERKI 
(n=6-7), and ERKO (n=7-9) for each time point. * WT compared to ERKO, p<0.05. 
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Figure 10: Photic phase response curve for male WT, NERKI, and ERKO mice (±SEM). 
Animals were pulsed with light for one hour at ZT 0, 4, 8, 16, and 22, and the phase response in 
minutes was determined. Sample size as follows: WT (n=5-7), NERKI (n=5-8), and ERKO 
(n=15-18) for each time point. There are no significant differences between groups at any of the 
tested time points. 
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Figure 11: Immunohistochemical Fos staining in the SCN following light pulses at ZT 4 and ZT 
16 for female (a) and male (b) WT, NERKI, and ERKO mice. Number of cells (±SEM) 
expressing Fos in the total SCN in response to light pulses at ZT 4 and ZT 16 for WT, NERKI, 
and ERKO males and females (n=3-5 per group). (c) There is a significant sex difference in total 
SCN Fos expression between ERKO mice at ZT16 (females greater than males, a relative to b, 
p<0.05). Among females, Fos expression in the total SCN increases in ERKO mice at ZT 16 
relative to ZT 4 (p<0.05 indicated by *). Among males, Fos expression in the total SCN 
increases in WT mice at ZT 16 relative to ZT 4 (p<0.05 indicated by +). 
 
a)  
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c)  
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Figure 12: Mean number of cells (±SEM) expressing Fos in the shell region of the SCN in 
response to light pulses at ZT 4 and ZT 16 for WT, NERKI, and ERKO males and females (n=3-
5 per group). Among females, Fos expression in the shell decreases from ZT 4 to ZT 16 in WT 
(* indicates p<0.05) and ERKO (+ indicates p<0.05) mice. Among males Fos expression in the 
shell decreases from ZT 4 to ZT 16 in WT (** indicates p<0.05) and NERKI mice (++ indicates 
p<0.05). Significant differences in Fos expression in the shell region at ZT 4 between WT males 
and ERKO males and NERKI males and ERKO males are indicated by * p<0.05. 
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Figure 13: Mean number of cells (±SEM) expressing Fos in the core region of the SCN in 
response to light pulses at ZT 4 and ZT 16 for WT, NERKI, and ERKO males and females (n=3-
5 per group). ERKO females have significantly more Fos expression in the core at ZT 16 than 
ERKO males (a relative to b). Among females, Fos expression in the core increases from ZT 4 to 
ZT 16 in WT (* indicates p<0.05) and ERKO (+ indicates p<0.05) mice. Among males Fos 
expression in the core increases from ZT 4 to ZT 16 in WT (** indicates p<0.05) and NERKI 
mice (++ indicates p<0.05). At ZT 16, male WT mice have significantly more Fos expression in 
the core than ERKO mice (indicated by * p<0.05). 
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CHAPTER 3 
 
Organizational and activational roles for estradiol in the expression of adult 
circadian rhythms and daily activity in female mice with impaired signaling at 
ESR1  
 
 
Abstract: 
Estradiol influences the level and distribution of daily activity, the duration of the free-
running period, and the behavioral phase response to light pulse. However, the 
mechanisms of estradiol regulation of these behaviors are not fully understood regarding 
where and when estrogens exert their influence. We tested the hypothesis that mediation 
of activity level and distribution in female mice includes both classical and “non-
classical” actions of estrogens at the estrogen receptor subtype 1 (ESR1). We used female 
transgenic mice with mutations in their estrogen response pathways: ESR1 knock-out 
(ERKO) mice lack the ability to respond to estrogens via ESR1 and “non-classical” 
estrogen receptor knock-in (NERKI) mice have an inserted ESR1 receptor with a 
mutation in the estrogen-response-element binding domain, allowing activation via “non-
classical” genomic and second messenger pathways. Ovariectomized female NERKI and 
ERKO mice and their wildtype (WT) littermates were given a subcutaneous capsule with 
low or high dose estradiol and compared to counterparts with no hormone replacement.  
We measured wheel-running activity in a light:dark cycle, in constant darkness, and the 
behavioral phase response to light pulses given at different points during the subjective 
day. Estradiol treatment increased total wheel-running levels and decreased the ratio of 
activity in the light relative to the dark phase in WT, but not NERKI and ERKO mice. 
The phase angle of activity onset during entrainment and the duration of the free-running 
period in constant darkness are affected by circulating hormones, but not genotype. These 
data suggest that estradiol action at ESR1 is primarily activational, and that this action 
increases total activity and decreases daytime activity.   
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Introduction: 
In females estradiol influences the daily amount and distribution of activity. 
Activational effects of hormones cause transient changes in the brain and behavior and 
changes that do not persist in the absence of that hormone (Arnold and Breedlove, 1985). 
Organizational effects of hormones are permanent changes in the brain and behavior 
caused by the presence of hormones during development or at specific critical periods. 
Gonadally intact female rats, hamsters, and degus have the greatest level of activity 
during proestrus and estrus when circulating estrogen levels are the highest (Morin et al., 
1977b, Wollnik and Turek, 1988, Mahoney et al., 2011). The stage of the reproductive 
cycle also influences the period of the free-running rhythm in constant conditions and the 
phase angle of activity onset in female rats, hamsters, and degus (Fitzgerald and Zucker, 
1976, Albers et al., 1981, Labyak and Lee, 1995). Ovariectomy of female rodents causes 
a decrease of activity and lengthening of tau, and estradiol replacement increases activity 
level, advances daily onset of activity, and shortens tau (Gentry and Wade, 1976, Morin 
et al., 1977b, Albers, 1981, Labyak and Lee, 1995). 
Developmental exposure to estrogens influences the expression of circadian 
activity in adulthood and modulates the acute effects of hormones on circadian regulation 
of adult activity. In male and female rats, duration of the free-running period is affected 
by perinatal exposure to steroid hormones. Perinatal exposure of female rats to androgens 
results in adult responses to estradiol modulation of free-running period that mirror male 
responses (Albers, 1981). A sex difference in phase angle in activity onset emerges 
during adolescence in degus. This phase angle is organized by the pre-pubertal gonadal 
hormone environment (Hummer, 2007). Adult aromatase knock-out mice that cannot 
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produce endogenous estradiol display decreased daily activity level, increased daytime 
activity, and alterations in their phase angle of activity onset relative to wildtype 
counterparts, suggesting that estradiol acting during development modifies the expression 
of rhythms in daily activity throughout life (Brockman et al., 2011). 
 Traditionally, estrogens mediate their actions through two distinct receptor 
subtypes: estrogen receptor subtype 1 (ESR1, or estrogen receptor alpha) and estrogen 
receptor subtype 2 (ESR2, or estrogen receptor beta). To exert action via “classical” 
nuclear receptor-mediated transcriptional activation, estrogens bind to receptors and the 
ligand-receptor complex then forms dimers that bind transcription factors. In the classical 
pathway, the hormone-receptor dimer binds to the estrogen response element (ERE) on 
regulatory regions of target genes to alter gene expression. There are also more recently 
characterized estrogen response pathways, including membrane receptor-associated 
estrogen receptors, that do not act via ERE-dependent transcription (Hall et al., 2001, 
Kousteni et al., 2001). “Non-classical” mechanisms of estrogen signaling include 
estrogenic action at non-ERE transcription factors, membrane-initiated action via protein 
kinases, and ligand-independent estrogenic signaling via second messenger pathways 
(McDevitt et al., 2008). Previous data from this and other labs provide strong evidence 
that estrogens acting at ESR1 increase wheel-running activity (Ogawa et al., 2003). 
However, it is unknown if these actions are regulated via classical ERE-dependent 
transcription or “non-classical” pathways acting acutely and during development. 
Here we will test the hypothesis that estrogen signaling at ESR1 mediates its 
effects on the expression of circadian rhythms and daily activity through both “classical” 
ERE-mediated and “non-classical” pathways. We will use two strains of mice with 
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transgenic modifications of their ability to respond to estrogens at ESR1. ESR1 knock-
out (ERKO) mice are unable to respond to either endogenously produced or administered 
estradiol via this receptor. “Non-classical” estrogen receptor knock-in (NERKI) mice 
retain the ability to bind estrogens at ESR1, however, a mutation in the ERE-binding 
domain prevents ERE-mediated transcription via this response pathway. The hormone-
receptor dimers can still act at non-ERE dependent transcription factors. Both strains 
retain the ability to respond to estrogens at ESR2. To isolate the organizational and 
activational effects of estradiol modification of circadian rhythms we used 
gonadectomized female NERKI, ERKO, and WT mice with and without estradiol 
replacement. We characterized their daily wheel-running behaviors in LD entrainment, 
constant dark conditions (DD), and determined the phase response to light pulses 
administered throughout the subjective day and night.   
 
Methods: 
Animal Breeding and Care 
 Adult female NERKI and ERKO mice and their WT littermates were used for 
these experiments. All mice were obtained from a breeding colony established at the 
University of Illinois. ERKO mice (Dr. Pierre Chambon, IGBMC, France) were obtained 
by mating males and females heterozygous for the mutation. NERKI mice (Dr. J. Larry 
Jameson, University of Pennsylvania, Philadelphia, PA) were generated from breeding 
heterozygous males containing one copy of the mutated ESR1 allele with females 
heterozygous for the ERKO mutation, as NERKI females are infertile. The non-classical 
estrogen receptor knock-in is thus on an ESR1 knock-out background. All genotypes 
 
 
! 73 
were confirmed using PCR. Control mice are WT littermates of NERKI and ERKO mice.  
Food and water were given ad libitum. Breeding animals and litters were 
maintained on Teklad 8626 rodent diet. Prior to activity monitoring, animals were given 
Teklad 2016 diet, which contains low soy estrogens (isoflavones) in the range of non-
detectable to 20 mg/kg, and remained on this diet for the remainder of the studies. All 
animal procedures were approved by the Institutional Animal Care and Use Committee of 
the University of Illinois and were conducted in accordance with the NIH Guide for the 
Care and Use of Laboratory Animals. 
 
Gonadectomy and estradiol replacement 
 Adult females (> two months old) were gonadectomized and given one of the 
following treatments: no hormone replacement, one silastic capsule containing estradiol 
benzoate in sesame oil (1E), or three capsules (3E). Silastic capsules (1.02 mm inner 
diameter; 10 mm in length) contained 1 mg/mL estradiol benzoate in sesame oil. The 
functionality of estradiol capsules was determined by vaginal cytology and measuring 
uterine horn wet weight in a subset of ovariectomized WT female animals with no, one, 
or three capsules.  
 
Determination of Daily Activity Patterns and Circadian Parameters 
Mice were maintained in 12 hour light : 12 hour dark (LD) cycles unless 
otherwise indicated, and the light intensity in the cages ranged from 220-360 lux (average 
290 lux). Mice were individually housed in cages (28 x 16 x 12cm) equipped with a 
metal wheel affixed to the top of the cage. Wheel revolutions were registered by a 
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magnetic switch and recorded in 10-minute bins of activity. Wheel-running activity was 
recorded and visualized using VitalView and ActiView (MinitMitter, Bend, OR). 
Activity was measured as wheel-running, collected into 10-minute bins. Activity was 
defined as each bin showing greater than 10 percent of the bin with the peak daily 
activity. The following variables were quantified: average daily wheel revolutions, ratio 
of activity in light compared to dark (LD ratio), phase angle of activity onset relative to 
lights-off, duration of free-running period (tau), and length of active phase (alpha) in 
constant dark (DD) conditions. For all parameters in 12:12 LD entrainment (activity 
distribution, total activity, LD ratio, and phase angle) measures were calculated from at 
least 5 consecutive days.  
The total daily wheel revolutions for each animal were calculated based on five 
consecutive days in 12:12 LD. These averages were then used to calculate the group 
averages for each genotype and sex. LD ratios were averaged for 5 days for each 
individual animal, and then these values were averaged to determine the LD ratio for 
each group. 
The phase angle of activity onset is measured relative to the time of lights-off. 
Positive values indicate that the activity onset began after lights-off. The onset of the 
daily activity bout was defined as the first of three consecutive 10-minute bins of activity 
that were not separated by more than two 10-minute bins of inactivity before the next 
recorded active bout. 
The free-running period (tau) was recorded in DD conditions for at least 7 days. 
Data from the first 3 days in constant conditions were disregarded to avoid transition 
effects. The tau value was obtained from a periodogram analysis of wheel-running 
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activity using ActiView. The duration of the period of sustained activity during constant 
conditions (alpha) was calculated from 5 days of consecutive activity and averaged for 
each animal. Activity duration was measured from the onset of the daily activity bout to 
its cessation. Onset of activity was defined as above for phase angle. Activity cessation 
was defined as the last active bin in a period of consecutive activity of least 40 min that 
preceded at least two hours with no sustained activity. 
 
Determination of Phase Response to Light-Pulse 
 The behavioral shift in activity that results from a light-pulse given at different 
times of the subjective day is called a phase response. A modified Aschoff Type II 
procedure was used which enables us to pulse animals with light before their free-running 
rhythms drift significantly after entrainment to the light cycles. Animals were housed in a 
12:12 LD cycle for at least 5 days; they were then placed in constant darkness for at least 
24 hours prior to a one-hour light-pulse at different times during their subjective day or 
night which correspond with the former Zeitgeber times (ZT) 4, 16, and 22 (ZT 0= lights-
on, ZT 12= lights-off). Following the light pulse, animals were returned to constant 
darkness for at least 7 days. 
 The phase response, measured in minutes, was calculated as the difference 
between the pre-pulse and post-pulse regression lines on the day following the light 
pulse. The pre-pulse regression line was determined by the onset of activity for at least 3 
days prior to the light-pulse. The post-pulse regression line was determined for 7 days in 
constant conditions, disregarding the day immediately following the light pulse to avoid 
transition effects.  
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Statistical Analysis 
 Total daily activity, LD ratio, phase angle of activity onset, and tau and alpha in 
constant conditions were analyzed with two-factor ANOVAs using genotype and 
treatment as independent factors (SYSTAT). A priori post hoc comparisons were 
performed to determine differences within a treatment condition or within a genotype. 
Behavioral shifts (min) were analyzed with two-factor ANOVA with treatment and 
genotype as independent factors (SYSTAT) for each time point separately (ZT 4, 16, and 
22). A priori post-hoc comparisons were then performed for each genotype to determine 
effects of gonadal status, and comparisons were made between genotypes with the same 
gonadal status (no hormone replacement, one estradiol capsule, three estradiol capsules). 
Differences were significant when p < 0.05. 
 
Results: 
Total activity and activity distribution during LD entrainment 
 We measured total daily wheel-running activity of female WT, NERKI, and 
ERKO mice with and without estradiol replacement. Total activity levels were 
significantly affected by genotype [F(2,59)=6.886, p=0.002] and treatment 
[F(2,59)=5.227, p=0.008] (Figure 14). There was no significant interaction between 
genotype and treatment. Post hoc analysis was used to identify differences between 
groups. In WT females, high dose estradiol replacement (3E) increased total activity 
relative to animals without hormone replacement (10,526±248 revolutions relative to 
5014±970 revolutions, p=0.048). Low dose (1E) estradiol did not significantly increase 
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wheel-running activity in WT females. In gonadectomized NERKI and ERKO females, 
neither dose of estradiol treatment caused a significant increase in wheel-running activity. 
WT mice with high and low dose estradiol treatment have significantly greater activity 
relative to ERKO females with the same treatments ((p<0.05 for both comparisons). Total 
wheel-running activity of NERKI females with high dose estradiol replacement is 
intermediate to WT and ERKO mice and is not significantly different from either group.  
 The amount of activity during the light phase relative to the dark phase is 
described by the LD ratio. We found significant effects of genotype [F(2,60)=4.965, 
p=0.01] and treatment [F(2,60)=5.031, p=0.01] on LD ratio (Figure 15). There is no 
significant interaction between genotype and treatment. Within WT females, high dose 
estradiol replacement decreases LD ratio relative to no hormone replacement (0.04±0.017 
for no replacement relative to 0.14±0.034 for 3E, p<0.05). Among NERKI and ERKO 
females, estradiol replacement did not significantly consolidate activity to the dark phase 
of the LD cycle relative to ovariectomized mice without hormone replacement. When 
female mice with high dose estradiol replacement were compared, WT mice had 
significantly more consolidated activity than ERKO mice (p<0.05), whereas NERKI mice 
with high dose estradiol treatment did not differ from either WT or ERKO females. 
Within WT females, mice with high dose estradiol treatment were significantly more 
nocturnal than the no treatment group (p<0.05), and females with low dose estradiol 
replacement have an LD ratio that is intermediate and not significantly different than 
either group.  
 The onset of wheel-running activity relative to the time of lights-off is the phase 
angle. Positive phase angle reflects onset of activity after lights-off. There was a 
 
 
! 78 
significant effect of hormone treatment on phase angle [F(2,59)=15.375, p<0.01] (Figure 
16). There was no significant effect of genotype or interaction between genotype and 
treatment. Among all females (WT, NERKI, and ERKO), treatment with low dose of 
estradiol significantly advances the onset of activity relative to lights-off relative to mice 
with no hormone replacement (p<0.05 in all groups). For both WT and ERKO females 
high dose estradiol replacement also advances phase angle relative to no hormone 
replacement (p<0.05 in both groups). The phase angle in NERKI females with low dose 
estradiol replacement is advanced relative to WT females (p<0.05). 
 
Free-running period and active period during constant darkness 
 The duration of the free-running period during constant darkness is tau. We found 
a significant effect of treatment on tau [F(2,60)=4.193, p=0.02] using a two-factor 
ANOVA with genotype and treatment as independent factors (Figure 17). Among WT 
animals, high dose estradiol replacement significantly shortens tau relative to no hormone 
replacement (23.6±0.11 hours and 24.95±0.02 hours, respectively, p<0.05). There was no 
significant effect of genotype or an interaction between genotype and treatment. Estradiol 
treatments had no effect on tau for NERKI or ERKO animals. There are no significant 
genotype differences within any of the treatment conditions. 
 The duration of the activity period during free-running in constant conditions is 
alpha. We found a significant effect of genotype on alpha [F(2,60)=10.744, p<0.01] 
(Figure 18), but no significant effect of treatment or interaction between genotype and 
treatment. In gonadectomized animals, NERKI females had a shorter duration of alpha 
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than WT (p=0.052) and ERKO (p<0.05) females. Within a genotype, replacement of low 
or high dose estradiol did not significantly alter alpha in WT and NERKI mice. 
 
Phase response to light pulse 
 The response to light pulses given at different times in the subjective day and 
night is described by the phase response curve. All groups tested displayed a typical 
phase response curve with a phase advance in response to light pulse late in the 
subjective night (ZT 22) and a phase delay in response to light pulse early in the 
subjective night (ZT 16). The magnitude of the phase response to light pulses given at ZT 
4, ZT 16, or ZT 22 was not significantly altered by genotype or treatment (Figure 19). 
 
 Discussion: 
We characterized the daily activity level and distribution, the free-running period, 
and the behavioral response to light pulses given at different times in the subjective day 
in ovariectomized female NERKI, ERKO, and WT mice with and without estradiol 
replacement. We found that WT animals with high dose estradiol replacement have 
increased wheel-running activity (Figure 14) and a more nocturnal LD ratio (Figure 15) 
relative to mice without hormone treatment. In contrast, estradiol replacement at a high 
dose did not significantly increase activity levels or decrease LD ratio in ERKO or 
NERKI mice. Interestingly, for measures of total activity and LD ratio, NERKI mice 
have intermediate total daily wheel-running and LD ratio relative to WT and ERKO 
mice, and are not significantly different than either group. Together, these data indicate 
that estradiol acting at ESR1 modulates the level and distribution of total daily activity. 
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This is the first time that estrogenic regulation of activity level has been shown to be 
mediated via both ERE-dependent and ERE-independent signaling. 
 We also calculated the phase angle of activity onset (Figure 16). Interestingly, 
despite deficits in estradiol receptor function, for all genotypes, estradiol treatment 
advanced phase angle relative to animals without hormone treatment. There are no 
significant differences among genotypes with no or high dose estradiol replacement. This 
suggests that estradiol modulates the timing of the daily activity onset via ESR1-
independent actions, which is in contrast to the mechanisms regulating activity. 
 Free-running rhythms in constant conditions depend on estradiol in WT animals; 
animals with a high dose of estradiol have a shorter free-running period relative to 
untreated and animals treated with a low dose of estradiol (Figure 17). Estradiol treatment 
did not change tau in NERKI and ERKO mice, which suggests that estradiol acts via 
ESR1 ERE-mediated pathways to modulate the duration of the free-running period. In 
contrast, the behavioral phase shifts in response to light pulse does not depend on either 
genotype or treatment (Figure 19). 
 Activity level and distribution in LD and tau appear to be modulated by 
activational effects of estradiol. However, our data also indicate estradiol has a 
developmental effect on activity, specifically the duration of the daily active bout during 
constant darkness. We found significant differences in alpha in DD among 
ovariectomized mice without estradiol replacement. In the absence of circulating 
hormones, NERKI mice have significantly shorter alpha than both WT and ERKO mice 
(Figure 18). There are no statistically significant differences following estradiol 
replacement among the genotypes. 
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 Our data indicating that estradiol action at ESR1 increases wheel-running activity 
following ovariectomy are consistent with previous reports (Ogawa et al., 2003). To our 
knowledge, this is the first study that indicates both ERE-dependent and “non-classical” 
roles of downstream estradiol activation to modulate wheel-running activity. Overall, our 
data add support to the well-known activational role of steroid hormones on activity level 
and extend this work by identifying the molecular mechanisms underlying this effect. It is 
well-established that circulating estradiol increases activity (Morin et al., 1977a, Albers et 
al., 1981, Wollnik and Turek, 1988, Labyak and Lee, 1995). In previous studies and in 
the current data, estradiol treatment to ovariectomized animals increases activity in adult 
WT mice (Gentry et al., 1976, Morin et al., 1977b, Albers, 1981, Labyak and Lee, 1995). 
Our data indicate that the consolidation of activity to the dark phase (or the decrease in 
daytime activity) is mediated by similar mechanisms of estradiol action, as we see 
significantly decreased LD ratio in WT animals only and an intermediate LD ratio in 
NERKI mice with high dose estradiol replacement relative to WT and ERKO mice with 
the same treatment. 
 The phase angle of activity onset has also been characterized in different species 
across the estrus cycle. Animals have advanced activity onset on days of high circulating 
estrogens (Fitzgerald and Zucker, 1976, Morin et al., 1977a, Albers et al., 1981, Wollnik 
and Turek, 1988, Labyak and Lee, 1995). In the current study, in all genotypes, estradiol 
replacement advanced the onset of activity relative to ovariectomized mice with no 
hormone replacement. These results indicate that the presence of circulating estradiol 
advances the onset of activity via ESR1-independent pathways. This could indicate a role 
of ESR2 in the modulation of phase angle. 
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 It should be noted that the doses of estradiol sufficient to increase wheel-running 
and alter patterns of daily activity in WT females in the present study were lower than the 
doses normally used to induce female sexual behaviors. Serum concentrations of estradiol 
were determined for a subset of mice and were less than the detectable level of the assay 
(<9 pg/mL) even with the high estradiol replacement group. Nevertheless, we find 
stimulatory effects of estradiol on wheel-running in WT females in this study, 
comparable to reported doses sufficient to measure differences locomotor behavior 
(Ogawa et al., 2003). 
 In addition to estradiol modulation of entrainment and total activity, estradiol has 
been shown to influence the circadian time-keeping system during constant darkness. 
Tau, the duration of the subjective day in constant conditions, is mediated directly by the 
master circadian oscillator, the suprachiasmatic nucleus (SCN). Ovariectomy lengthens 
tau, and estradiol replacement shortens tau in constant darkness in female rats and 
hamsters (Zucker et al., 1980, Albers, 1981). In the present study estradiol replacement to 
ovariectomized mice decreases tau in WT, but not ERKO mice. NERKI mice are 
intermediate and not significantly different than either WT or ERKO mice with high 
estradiol replacement, indicating that both ERE-dependent and non-classical actions of 
estradiol at ESR1 mediate the ability of estradiol to decrease tau. 
 All groups tested had a similar phase-dependent pattern of behavioral shift in 
response to light pulses given during the subjective day and night, consistent with the 
patterns described for other species (Daan and Pittendrigh, 1976). Animals had phase 
advances in response to light pulse given late subjective night and a phase delay in 
response to pulses given early in the subjective night. We hypothesized that animals with 
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differential ability to respond to circulating estradiol would have attenuated responses to 
light pulse, as we have previously shown genotype affects the phase response curve of 
ERKO and NERKI mice. However, there are no significant differences between genotype 
or treatment groups in the behavioral phase response to light early and late in the 
subjective night. In aromatase knock-out mice, that do not produce endogenous estradiol, 
there are significant differences in the phase response curve following gonadectomy 
(Brockman et al., 2011). This suggests the possibility that estrogens can maintain the 
phase response functionality through alternate, non-ESR1, estrogenic signaling pathways. 
 Mice with selective inability to respond to estradiol at ESR1 provide the 
opportunity to study how hormones at this receptor influence circadian rhythms and daily 
activity via both activational and organizational mechanisms. This study confirms 
previously reported activational effects of estradiol on daily activity level and distribution 
and also indicates a potential developmental role of estradiol on some circadian 
parameters (alpha). With the NERKI mice, this study also indicates a role for non-
classical estrogen signaling via non-ERE-dependent pathways in estrogenic modulation 
of daily activity and circadian rhythms. Together, these data shed light on the 
mechanisms of estrogenic modulation of circadian rhythms in females and further 
characterize the role of ESR1-dependent behaviors. 
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Figure 14: Total daily wheel-running activity (±SEM) for WT, NERKI, and ERKO 
gonadectomized females with no hormone replacement (gdx: white bar) and low (1E: red  
bar) and high dose (3E: black bar) estradiol replacement. There are significant differences 
between WT and ERKO females with 3E (a relative to b, p<0.05) and 1E (c relative to d, 
p<0.05). * indicates significant differences WT females with 3E relative to no hormone 
treatment (p<0.05). Sample sizes for the groups as follows: WT (n=7-9/group), NERKI 
(n=8/group for gdx and 3E, n=4 for 1E), and ERKO (n=8/group). 
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Figure 15: LD ratio (±SEM) for WT, NERKI, and ERKO gonadectomized females with 
no hormone replacement (gdx: white bar) and low (1E: red bar) and high dose (3E: black 
bar) estradiol replacement. There is a significant difference between WT and ERKO 
females with 3E (a relative to b, p<0.05). * indicates significant differences between WT 
females with 3E and no hormone treatment (p<0.05). Sample sizes for the groups as 
follows: WT (n=7-9/group), NERKI (n=8/group for gdx and 3E, n=4 for 1E), and ERKO 
(n=8/group). 
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Figure 16: Phase angle of activity onset relative to lights-off (min after lights-off) 
(±SEM) for WT, NERKI, and ERKO gonadectomized females with no hormone 
replacement (gdx: white bar) and low (1E: red bar) and high dose (3E: black bar) 
estradiol replacement. There is a significant differences between WT and NERKI females 
with 1E (a relative to b, p<0.05). WT, NERKI, and ERKO females all have significantly 
advanced phase angles with E treatment relative to no hormone treatment, and WT and 
ERKO females with 3E treatment have advanced activity onset relative to no treatment (* 
indicates significant differences for these comparisons (p<0.05). Sample sizes for the 
groups as follows: WT (n=9-10/group), NERKI (n=7-8/group for gdx and 3E, n=3 for 
1E), and ERKO (n=7-8/group). 
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Figure 17: Free-running period (tau) in constant darkness (hours) (±SEM) for WT, 
NERKI, and ERKO gonadectomized females with no hormone replacement (gdx: white 
bars) and low (1E: red bar) and high dose (3E: black bar) estradiol replacement. WT 
females with 3E treatment have decreased tau relative to WT females with no hormone 
replacement (* indicates significant differences p<0.05). Sample sizes for the groups as 
follows: WT (n=8-9/group), NERKI (n=8/group for gdx and 3E, n=4 for 1E), and ERKO 
(n=7-8/group). 
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Figure 18: Duration of the active period (alpha) (±SEM) in constant darkness (min) for 
WT, NERKI, and ERKO gonadectomized females with no hormone replacement (gdx: 
white bar) and low (1E: red bar) and high dose (3E: black bar) estradiol replacement. 
There are significant differences between WT and NERKI females with no treatment (a 
relative to b, p<0.05) and NERKI and ERKO females with no hormone treatment (b 
relative to c, p<0.05). Among ERKO females, 3E treatment decreases alpha relative to 
ERKO females with no treatment and with low does (E) estradiol treatment (* indicates 
significant differences for both comparisons, p<0.05). Sample sizes for the groups as 
follows: WT (n=7-9/group), NERKI (n=8-9/group for gdx and 3E, n=4 for 1E), and 
ERKO (n=7-8/group). 
 
  
 
 
! 89 
Figure 19: Behavioral phase response to light pulse (min) given during the subjective 
day (ZT 4, ZT 16, ZT 22) for WT (black bars), NERKI (gray bars), and ERKO (white 
bars) gonadectomized females with no hormone (gdx) replacement, low (E), and high 
dose (3E) estradiol replacement. Negative values indicate a phase delay and positive 
values indicate a phase advance. There are significant differences between NERKI and 
ERKO females with 1E (a relative to b, p<0.05). * indicates significant differences 
between treatment groups within a genotype (p<0.05). Sample sizes for the groups as 
follows: For ZT 4, WT (n=7-8/group), NERKI (n=9 for gdx, n=4 for 1E, n=3 for 3E), and 
ERKO (n=7/group). For ZT 16, WT (n=7-9/group), NERKI (n=9 for gdx, n=4 for 1E, 
n=3 for 3E), and ERKO (n=7-8/group). For ZT 22, WT (n=7-8/group), NERKI (n=9 for 
gdx, n=3 for 1E, n=8 for 3E), and ERKO (n=6-8/group). 
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CHAPTER 4 
 
Insights into the organizational and activational effects of estrogens on circadian 
rhythms in male mice with transgenic disruptions in estrogen receptor subtype 1  
 
 
 
Abstract: 
Gonadal hormones modify the expression of circadian rhythms in adults and influence 
the level and distribution of activity across the light-dark cycle. There are sex differences 
in the expression of circadian rhythms that depend on steroid hormones, however, the 
mechanisms of hormone action in regulation of these rhythms are not fully understood. 
There is evidence that estradiol regulates activity level and patterns in females, however 
the modulatory role of estradiol on circadian rhythms in males is unknown. Here we test 
the hypothesis that mediation of activity level and distribution in male mice includes both 
classical and “non-classical” actions of estrogens at the estrogen receptor subtype 1 
(ESR1). We aim to characterize how and when estrogens act during development to 
modify the expression of circadian rhythms. We used male transgenic mice with 
mutations in their estrogen response pathways: ESR1 knock-out (ERKO) mice lack the 
ability to respond to estrogens via ESR1 and “non-classical” estrogen receptor knock-in 
(NERKI) mice have an inserted ESR1 receptor with a mutation in the estrogen-response-
element binding domain, allowing activation via “non-classical” genomic and second 
messenger pathways. Gonadectomized male NERKI, ERKO, and their wildtype (WT) 
littermates were given a subcutaneous estradiol capsule with low or high dose and 
compared to counterparts with no hormone treatment. We measured wheel-running 
activity in a light:dark cycle and constant darkness and we also measured the behavioral 
phase response to light pulses given at different points during the subjective day. We 
found a significant effect of genotype on total activity, ratio of activity during the light 
relative to the dark phase, free-running period, and duration of active period. Estradiol 
treatment consolidates activity to the dark phase in WT males but not ERKO males. 
Further, the NERKI phenotype partially restores activity consolidation to the dark phase 
in mice treated with estradiol. These data provide new information about the activational 
and organizational effects of “non-classical” and ESR1-dependent estrogenic 
modification of circadian rhythms. Identifying how and when estrogens modify circadian 
behaviors will contribute to understanding the etiology of sex differences in circadian 
rhythms and sleep disorders. 
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Introduction: 
Gonadal hormones influence circadian rhythms and activity patterns by 
modifying the amount and distribution of daily activity, the intrinsic free-running period 
(tau) in constant conditions, and the phase response to light pulse (Mong et al., 2011). 
Yet how these hormones exert their effects remains to be determined. Secondly, how 
these hormones regulate circadian rhythms and activity differentially in males and 
females is relatively unknown. Hormones are traditionally described as having 
activational and organizational effects. Acute responses to the presence of hormones are 
activational; hormones cause transient changes in the brain and behavior and these 
changes do not persist in the absence of that hormone (Arnold and Breedlove, 1985). In 
females, there is a well-established effect of reproductive cycle stage on circadian 
rhythms and activity level; on days of high circulating estrogens, there is increased 
activity, advanced activity onset, and increased duration of activity (Morin et al., 1977, 
Albers et al., 1981, Wollnik and Turek, 1988). Estradiol replacement to gonadectomized 
animals confirms that these changes over the reproductive cycle are due to circulating 
estrogens (Gentry and Wade, 1976, Morin et al., 1977, Albers, 1981, Labyak and Lee, 
1995). Estradiol may have differential roles in males and females. Estradiol treatment 
following gonadectomy decreases the free-running period in female rats, however, in 
male rats estradiol either increases or decreases the length of tau as a function of the 
individual pre-treatment tau (Albers, 1981). 
Organizational effects of hormones are indicated when the hormone itself is 
removed from the system yet the change persists; these effects are permanent changes in 
the brain and behavior caused by the presence of hormones during development or at 
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specific critical periods. There is evidence for an organizational role of estrogens during 
development on the expression of circadian rhythms in adults. In male and female rats, 
the change in free-running period that results from gonadectomy and hormone 
replacement in adulthood is affected by perinatal exposure to steroid hormones (Albers, 
1981). Other circadian parameters are modified by organizational activity of gonadal 
hormones. In degus, the phase angle of activity onset relative to the LD cycle changes 
during adolescence and depends on the presence of gonadal hormones during 
development (Hummer, 2007).  
In male mice, androgens have a regulatory role on activity and circadian rhythms; 
gonadectomy increases free-running period, decreases daily activity, and alters the 
distribution of wheel-running across the day and androgen administration following 
gonadectomy restores these patterns to that of intact animals (Daan et al., 1975, 
Karatsoreos et al., 2007, Iwahana et al., 2008). However, there is evidence that estrogens 
also modify circadian behaviors in males. Aromatase knock-out mice (ArKO) lack 
endogenous circulating estrogens and intact and gonadectomized male ArKO mice have 
decreased total activity and altered distribution of activity throughout the LD cycle 
relative to wildtype (WT) counterparts (Brockman et al., 2011). Differences in circadian 
behavior between ArKO mice and WT littermates that persist following gonadectomy 
indicate an organizational role for estrogenic modification of circadian rhythms in 
adulthood.  
Estrogen signaling is mediated through two distinct nuclear receptors: estrogen 
receptor subtype 1 (ESR1) and estrogen receptor subtype 2 (ESR2), as well as more 
recently characterized “non-classical” pathways, (Hall et al., 2001, Kousteni et al., 2001). 
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To exert action via nuclear receptor-mediated transcriptional activation, estrogens bind to 
receptors and the ligand-receptor complexes form dimers that the bind transcription 
factors. In the “classical” pathway, the hormone-receptor dimer binds to the estrogen 
response element (ERE) on regulatory regions of target genes to alter gene expression. 
“Non-classical” mechanisms of estrogen signaling include the action of dimers at non-
ERE transcription factors, membrane-initiated action via protein kinases, and ligand-
independent estrogenic signaling via second messenger pathways (McDevitt et al., 2008).  
In this study, our goal was to investigate the organizational and activational role 
of estrogens in modifying the expression of circadian activity in males. We hypothesized 
that estradiol influences activity level and distribution, free-running rhythms, and 
response to light pulse via activational effects of the hormone at both ERE-dependent and 
independent pathways. To test this hypothesis, we used ESR1 knock-out (ERKO) and  
“non-classical” estrogen receptor knock-in (NERKI) mice. ERKO mice lack ESR1, and 
NERKI mice have a mutation in the ERE-binding domain of a knocked-in ESR1. NERKI 
mice can still respond to estrogens binding ESR1 via non-ERE-mediated mechanisms. 
Both transgenic strains retain intact ESR2 receptors. To characterize the organizational 
and activational effects of estrogens on circadian activity we used gonadectomized 
NERKI, ERKO, and their WT littermates, with and without estradiol replacement. We 
hypothesized that circulating estrogens both during development and adulthood modify 
the level and distribution of daily activity across a LD cycle. We will also test the 
hypothesis that differences in entrainment activity and circadian rhythms among 
treatment and genotype groups are due to different responses to light; to test this we will 
 
   
! 96 
characterize activity in constant conditions and the behavioral response to light-pulse to 
better understand how and where estrogens act to influence circadian rhythms. 
 
 
Methods: 
 
Animal Breeding and Care 
 Adult male NERKI and ERKO mice and their WT littermates were used for these 
experiments. All mice were obtained from a breeding colony established at the University 
of Illinois. ERKO mice (Dr. Pierre Chambon, IGBMC, France) were obtained by mating 
males and females heterozygous for the mutation. NERKI mice (Dr. J. Larry Jameson, 
University of Pennsylvania, Philadelphia, PA) were obtained from breeding heterozygous 
males containing one copy of the mutated ESR1 allele with females heterozygous for the 
ERKO mutation, as NERKI females are infertile. The non-classical estrogen receptor 
knock-in is thus on an ESR1 knock-out background. All genotypes were confirmed using 
PCR. Control mice are wildtype littermates of NERKI and ERKO mice.  
Food and water were given ad libitum. Breeding animals and litters were 
maintained on Teklad 8626 rodent diet. Prior to activity monitoring, animals were given 
Teklad 2016 diet, which contains low soy estrogens (isoflavones) in the range of non-
detectable to 20 mg/kg, and remained on this diet for the remainder of the studies. All 
animal procedures were approved by the Institutional Animal Care and Use Committee of 
the University of Illinois and were conducted in accordance with the NIH Guide for the 
Care and Use of Laboratory Animals. 
 
Gonadectomy and estradiol replacement 
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 Adult males (> two months old) were gonadectomized and given one of the 
following treatments: no hormone replacement, one silastic capsule containing estradiol 
benzoate in sesame oil (1E), or three capsules (3E). Silastic capsules (1.02 mm inner 
diameter; 10 mm in length) contained 1 mg/mL estradiol benzoate in sesame oil. 
 
Determination of Daily Activity Patterns and Circadian Parameters 
Mice were maintained in 12 hour light : 12 hour dark (LD) cycles unless 
otherwise indicated, and the light intensity in the cages ranged from 220-360 lux (average 
290 lux). Mice were individually housed in cages (28 x 16 x 12cm) equipped with a 
metal wheel affixed to the top of the cage. Wheel revolutions were registered by a 
magnetic switch and recorded in 10-minute bins of activity. Wheel running activity was 
recorded and visualized using VitalView and ActiView (MinitMitter, Bend, OR). The 
following variables were quantified: average daily wheel revolutions, light:dark ratio of 
activity (LD ratio), phase angle of activity onset relative to lights-off, duration of free-
running period (tau), and length of active phase (alpha) constant dark (DD) conditions. 
For all parameters in 12:12 LD entrainment (activity distribution, total activity, LD ratio, 
and phase angle) measures were calculated from at least 5 consecutive days.  
The total daily wheel revolutions for each animal was calculated based on five 
consecutive days in 12:12 LD. These averages were then used to calculate the group 
averages for each genotype and sex. The LD ratio represents the activity during the light 
phase compared with the dark phase. LD ratios were averaged for 5 days for each 
individual animal, and then these values were averaged to determine the LD ratio for 
each group. 
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The phase angle of activity onset is measured relative to the time of lights-off. 
Positive values indicate that the activity onset began after lights-off. The onset of the 
daily activity bout was defined as the first of three consecutive 10-minute bins of activity 
that were not separated by more than two 10-minute bins of inactivity before the next 
recorded active bout. 
The free-running period (tau) was recorded in DD conditions for at least 7 days. 
Data from the first 3 days in constant conditions were disregarded to avoid transition 
effects. The tau value was obtained from a periodogram analysis of wheel-running 
activity using ActiView. The duration of the period of sustained activity during constant 
conditions (alpha) was calculated from 5 days of consecutive activity and averaged for 
each animal. Activity duration was measured from the onset of the daily activity bout to 
its cessation. Onset of activity was defined as above for phase angle. Activity cessation 
was defined as the last active bin in a period of consecutive activity of least 40 min that 
preceded at least two hours with no sustained activity. 
 
Determination of Phase Response to Light-Pulse 
 The behavioral shift in activity that results from a light-pulse given at different 
times of the subjective day is called a phase response. A modified Aschoff Type II 
procedure was used which enables us to pulse animals with light before their free-running 
rhythms drift significantly after entrainment to the light cycles. Animals were housed in a 
12:12 LD cycle for at least 5 days; they were then placed in constant darkness for at least 
24 hours prior to a one-hour light-pulse at different times during their subjective day or 
night which correspond with the former Zeitgeber times (ZT) 4, 16, and 22 (ZT=0 time of 
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lights-on, ZT=12 time of lights off). Following the light pulse, animals were returned to 
constant darkness for at least 7 days. 
 The phase response is measured in minutes and determined as the difference 
between the pre-pulse and post-pulse regression lines on the day following the light 
pulse. The pre-pulse regression line was determined by the onset of activity for at least 3 
days prior to the light-pulse. The post-pulse regression line was determined for 7 days in 
constant conditions, disregarding the day immediately following the light pulse to avoid 
transition effects. Activity was measured as wheel running, collected into 10-minute bins. 
Activity was defined as each bin showing greater than 10 percent of the bin with the peak 
daily activity.  
 
Statistical Analysis 
 Total daily activity, LD ratio, phase angle of activity onset, and tau and alpha in 
constant conditions were analyzed with a 2-factor ANOVA using genotype and treatment 
as independent factors (SYSTAT). A priori post hoc comparisons were performed to 
determine differences between groups within a treatment condition or within a genotype. 
For each time point, behavioral shifts (min) were analyzed with two-factor ANOVA with 
treatment and genotype as independent factors (SYSTAT). A priori post-hoc comparisons 
of groups were then performed to determine treatment differences within genotype or 
genotype differences within treatment. Differences were considered significant when p < 
0.05. ERKO males with low dose estradiol replacement are not included in the 
comparison because of sample size (n=2). 
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Results: 
Total activity level and activity distribution during LD 
 We measured total daily wheel-running activity of male WT, NERKI, and ERKO 
mice with and without estradiol replacement. We found an effect of genotype 
[F(2,56)=5.606, p=0.006] on total activity (Figure 20) with a two-factor ANOVA using 
genotype and treatment as independent factors. There was no significant effect of 
treatment on total activity level or an interaction between genotype and treatment. 
Planned post hoc analysis was used to identify differences between groups. In 
gonadectomized animals without estradiol replacement, there were no significant 
differences between genotype groups. However, among animals with a high dose (3E) 
estradiol replacement, ERKO mice had significantly decreased activity relative to WT 
animals (4621±1561 revolutions for ERKO and 13,614±3140 revolutions for WT males, 
p<0.05). NERKI males with a high dose estradiol replacement were intermediate relative 
to WT and ERKO animals and their activity was not significantly different than either 
group. With low dose (1E) estradiol replacement WT males had greater activity than 
NERKI males (p<0.05). 
 The amount of activity during the light phase relative to the dark phase is 
described by the LD ratio. We found significant effects of genotype [F(2,56)=6.079, 
p=0.004] and treatment [F(2,56)=5.705, p=0.006] on LD ratio (Figure 21), but no 
significant interaction between these variables. Among WT animals, both low and high 
dose estradiol replacement groups had decreased LD ratio relative to no hormone 
treatment (p<0.05 for both comparisons). NERKI males also responded to estradiol 
replacement and low and high dose estradiol replacement groups had decreased LD ratio 
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relative to no hormone replacement (p<0.05 for 1E and p=0.052 for 3E). In contrast, 
there were no treatment differences among ERKO males. Among gonadectomized males 
without hormone replacement, there were no significant genotype differences. With high 
dose estradiol treatment the activity of WT males was significantly more consolidated to 
the dark phase than both NERKI (p<0.05) and ERKO (p<0.05) males. 
 The onset of activity relative to the time of lights-off is the phase angle. Positive 
phase angle reflects onset of activity after lights-off. We found a significant effect of 
treatment on phase angle [F(2,57)=6.898, p=0.002] (Figure 22) but no significant effect 
of genotype or interaction between these variables. Post hoc analysis shows NERKI 
animals had significantly earlier activity onset when treated with high dose estradiol 
relative to no hormone treatment (p<0.05). 
 
Free-running period (tau) and duration of activity (alpha) during constant darkness 
 The duration of the free-running period during constant darkness is tau. We found 
significant effects of genotype [F(2,51)=4.048, p+0.023] and treatment [F(2,51)=4.932, 
p=0.011] on tau (Figure 23), but no interaction between these variables. Within WT 
males, high dose estradiol replacement significantly decreased tau relative to animals 
with no hormone replacement (23.7±0.02 and 23.96±0.07 hours, respectively, p<0.05). 
Estradiol treatment did not have a significant effect on tau in NERKI and ERKO 
genotypes. Among gonadectomized animals without hormone replacement, there were no 
genotype differences. With low dose estradiol replacement, NERKI males had increased 
tau relative to WT males (ERKO males are not included in this analysis, n=2). There 
were no genotype differences with high dose estradiol replacement. 
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 The duration of the activity bout during constant darkness is alpha. ANOVA test 
with treatment and genotype as independent factors revealed significant effects of 
genotype [F(2,52)=5.779, p=0.005] and treatment [F(2,52)=7.62, p=0.001] on alpha 
(Figure 24). There was not an interaction between genotype and treatment. Within WT 
and ERKO males, high dose estradiol replacement decreased the active period relative to 
no hormone treatment (p<0.05). There were no treatment differences among NERKI 
males. With high dose estradiol replacement, NERKI males had greater alpha than both 
WT and ERKO males (p<0.05 for both comparisons). There were no genotype 
differences between groups for mice with no hormone treatment or low dose estradiol 
treatment.  
 
Phase response to light pulse 
 The response to light pulse during constant darkness at different points in the 
subjective night is described by the phase response curve. All groups tested displayed a 
phase response curve typical of nocturnal rodents with a phase advance in response to 
light pulses given late in the subjective night (ZT 22) and phase delays in response to 
light pulse early in the subjective night (ZT 16). The phase responses to light pulses given 
at ZT 4 and ZT 16 were not influenced by genotype or treatment (Figure 25). At ZT 22 
there was a significant effect of treatment on phase response to light pulse 
[F(2,49)=6.538, p=0.003]. Post hoc analysis revealed that the phase response of NERKI 
males with high dose estradiol was increased relative to no hormone and low does 
estradiol (p<0.05 for both groups). 
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Discussion: 
 We characterized the daily activity level and distribution, the free-running period, 
and the phase response to light pulse in gonadectomized male mice with impairments in 
the ability to respond to estrogens at ESR1 compared to their WT littermates. To 
determine the modulatory role of estrogens acting during development and in adulthood 
on circadian rhythms, we also compared animals with low and high doses of estradiol 
benzoate treatment. A major finding presented here is the mechanism of estradiol 
mediation of the expression of daily wheel-running activity and circadian rhythms in 
male mice. Estradiol replacement to gonadectomized male mice increases wheel-running 
activity (Figure 20) and consolidates that activity to the dark phase of a light-dark cycle 
(Figure 21). The activational role of estradiol to increase activity appears to be via actions 
at ESR1, as previously described (Ogawa et al., 2003). However, a novel finding from 
this study indicates that estradiol mediates this action via both classical ERE-dependent 
signaling and non-classical non-ERE-dependent action at ESR1, as NERKI mice have 
total wheel-running level intermediate to WT and ERKO mice. 
The activational role of circulating estradiol contributes to activity distribution 
across the day in addition to total activity level. Among WT male mice, estradiol 
replacement decreases LD ratio relative to no replacement. Estradiol replacement also 
decreases LD ratio in NERKI, but not ERKO mice, suggesting that ESR1 is the point of 
hormone regulation on this parameter and that non-ERE dependent downstream actions 
are primarily, though not exclusively, responsible for the activity consolidation to the 
dark phase. 
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Finally, we see an influence of estradiol status on tau (Figure 23), but not the 
phase response to light pulse in male mice (Figure 25). Interestingly, the presence of 
estradiol selectively alters tau, but not the phase response to light pulse, parameters that 
are usually linked. There are no significant differences between genotype or treatment 
groups in the magnitude of the behavioral response to light pulses given either early or 
late in the subjective night. All treatment groups within each genotype responded to light 
pulses with a phase advance or a phase delay typical to nocturnal rodents (Daan and 
Pittendrigh, 1976). 
It is important to note that the doses of estradiol sufficient to increase wheel-
running and observe behavioral differences in WT males in the present study were lower 
than the doses normally used to induce female sexual behaviors. Serum concentrations of 
estradiol were determined for an independent group of mice and were less than the 
detectable level of the assay (<9 pg/mL) even with the high estradiol replacement group. 
Nevertheless, we find stimulatory effects of estradiol on wheel-running in WT males in 
this study, comparable to reported doses sufficient to measure differences locomotor 
behavior (Ogawa et al., 2003). 
Relatively few studies have examined the response of the circadian time-keeping 
system and daily activity to estradiol in males. The role of estradiol to influence the 
expression of circadian behaviors has been characterized to a greater extent in females 
than males. This study revels sex-differences in the mechanisms of estradiol mediation of 
circadian activity in males and females. In females, there is a well-established effect of 
reproductive cycle stage on circadian parameters and activity level (Morin et al., 1977, 
Albers et al., 1981, Wollnik and Turek, 1988). The amount of activity is increased, the 
 
   
! 105 
phase angle of activity onset is advanced, and the duration of the active period is 
increased on days when circulating estrogens are highest during the rodent reproductive 
cycle (Morin et al., 1977, Albers et al., 1981, Wollnik and Turek, 1988, Labyak and Lee, 
1995). These changes are due to activational effects of estradiol, as hormone replacement 
to gonadectomized animals also increases total daily activity and advances activity onset 
(Gentry and Wade, 1976, Morin et al., 1977, Albers, 1981, Labyak and Lee, 1995). 
Estradiol modulation of circadian activity is measured in light-dark entrainment and in 
constant conditions. In addition to the level of activity, estradiol modulates the phase 
angle of activity onset relative to the dark phase (Fitzgerald and Zucker, 1976, 
Pittendrigh and Daan, 1976, Albers et al., 1981, Labyak and Lee, 1995). In female rats, 
estradiol replacement decreases tau, but in males estradiol increases or decreases tau 
depending on the pretreatment free-running period, suggesting a homeostatic role of 
estradiol to modulate free-running rhythms and also the sensitivity of the adult male 
circadian system to estrogens (Albers, 1981). 
Sex differences have been described in the circadian time-keeping systems in 
humans and rodents (Mong et al., 2011). There are sex differences in activity distribution 
and the free-running rhythms in rodents (Gentry and Wade, 1976, Davis et al., 1983, 
Iwahana et al., 2008, Brockman et al., 2011), and the duration of the free-running period 
in humans (Duffy et al., 2011). These sex differences could be due to sexual dimorphisms 
in the central clock, the suprachiasmatic nucleus (SCN) itself (Hofman et al., 1988, 
Abizaid et al., 2004), the distribution of steroid receptors in the SCN (Iwahana et al., 
2008, Vida et al., 2008), and/or the differences in circulating gonadal hormones. 
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There are sexual dimorphisms in the SCN and the distribution of steroid receptors 
in the SCN itself and its peripheral projections. Sex differences in the development of the 
SCN depend on the presence of testosterone during development (Abizaid et al., 2004). 
The distribution of steroid receptors in the adult suprachiasmatic nucleus also shows 
significant sex differences. Both ESR1 and ESR2 are expressed to varying degrees in the 
mouse SCN (Shughrue, 1998) and there is greater expression of ESR2 relative to ESR1 
(Mitra et al., 2003). There are sex differences in the expression of estrogen receptors in 
the mouse SCN; in gonadectomized females about 4.5% of neurons in the SCN are 
positive for ESR1 relative to 3% for gonadectomized males and treatment with estrogens 
does not increase expression of ESR1 in either sex (Vida et al., 2008). In humans, there 
are estrogen receptors of both subtypes in the SCN, with significantly greater ESR1 
expression in females relative to males (Kruijver and Swaab, 2002). Androgen receptors 
are present to a greater degree in males than females in intact mice; gonadectomy 
eliminates and testosterone treatment restores the sex differences in androgen receptor 
expression in the SCN (Iwahana et al., 2008). 
In males, evidence points to a role of testosterone modulation of the level and 
distribution of daily activity and the regulation of the expression of circadian rhythms 
(Karatsoreos et al., 2007). Gonadectomy decreases early evening activity in male mice 
and testosterone replacement restores the activity (Iwahana et al., 2008). 
While androgens are expressed to a greater degree than estrogens in intact males, 
and may be the primary regulator of circadian rhythms in males, this study suggests that 
adult male mice can still respond to exogenous estrogens and that estradiol also can play 
a role in modulating the level and distribution of activity and modify the expression of 
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circadian rhythms. These differences appear to be mediated by primarily activational, not 
organizational effects of hormones. Further, estradiol modulation of activity level and 
distribution is mediated by estrogens acting at ESR1 via both ERE-dependent and ERE-
independent transcriptional pathways. 
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Figure 20: Total wheel-running (±SEM) in 24 hours for WT, NERKI, and ERKO 
gonadectomized males with no hormone (gdx: white bars) replacement and low (E: blue 
bar) and high dose (3E: black bar) estradiol replacement. NERKI mice with 1E treatment 
have significantly decreased activity relative to WT mice with 1E treatment (a relative to 
b, p<0.05). Among animals with high does estradiol treatment (3E) ERKO mice have 
decreased activity relative to WT males (c relative to d, p<0.05). In NERKI males, low 
dose estradiol decreases total activity relative to no treatment (* indicates p<0.05). 
Sample sizes for the groups as follows: WT (n=7-8/group), NERKI (n=8-10/group), and 
ERKO (n=7-8/group for gdx and 3E, n=2 for E). 
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Figure 21: LD ratio  (±SEM) for WT, NERKI, and ERKO gonadectomized males with 
no hormone replacement (gdx: white bar) and low (E: blue bar) and high dose (3E: black 
bar) estradiol replacement. Among animals with high dose estradiol treatment, WT males 
have significantly lower LD ratio that NERKI (a relative to b, p<0.05) and ERKO (a 
relative to c, p<0.05) males. In NERKI and ERKO males, low (E) and high (3E) dose 
estradiol significantly decrease LD ratio relative to no treatment (differences indicated 
with *, p<0.05). Sample sizes for the groups as follows: WT (n=6-10/group), NERKI 
(n=7-8/group), and ERKO (n=7-8/group for gdx and 3E, n=2 for E). 
 
  
 
   
! 110 
Figure 22: Phase angle of activity onset relative to lights-off (min after lights-off) 
(±SEM) for WT, NERKI, and ERKO gonadectomized males with no hormone 
replacement (gdx: white bar) and low (E: blue bar) and high dose (3E: black bar) 
estradiol replacement. 3E treated NERKI males have advanced phase angle relative to 
NERKI males without treatment (* indicates p<0.05). Sample sizes for the groups as 
follows: WT (n=6-10/group), NERKI (n=7-8/group), and ERKO (n=8/group for gdx and 
3E, n=2 for E). 
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Figure 23: Free-running period (tau) (±SEM) in constant darkness (hours) for WT, 
NERKI, and ERKO gonadectomized males with no hormone replacement (gdx: white 
bar) and low (E: blue bar) and high dose (3E: black bar) estradiol replacement. For 
animals with low dose estradiol replacement, NERKI males have increased tau relative to 
WT males (a relative to b, p<0.05). In WT mice, 3E treated mice have decreased tau 
relative to mice without estradiol treatment (* indicates p<0.05). Sample sizes for the 
groups as follows: WT (n=5-7/group), NERKI (n=7-10/group), and ERKO (n=7/group 
for gdx and 3E, n=2 for E). 
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Figure 24: Duration of the active period (alpha) (±SEM)  in constant darkness (min) for 
WT, NERKI, and ERKO gonadectomized males with no hormone replacement (gdx: 
white bar) and low (E: blue bar) and high dose (3E: black bar) estradiol replacement. 
Among animals with high dose estradiol treatment, NERKI males have increased alpha 
relative to both WT (a relative to b, p<0.05) and ERKO (b relative to c, p<0.05) males. In 
WT and ERKO males, 3E treated males have decreased alpha relative to no treatment (* 
indicates p<0.05 for both comparisons). Sample sizes for the groups as follows: WT 
(n=7-8/group for gdx and 3E, n=4 for E), NERKI (n=8-10/group), and ERKO (n=7/group 
for gdx and 3E, n=2 for E). 
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Figure 25: Behavioral phase response (min) (±SEM) to light pulses given during the 
subjective day (ZT 4, ZT 16, ZT 22) for WT (black bars), NERKI (gray bars), and ERKO 
(white bars) gonadectomized males with no hormone replacement (gdx) and low (E) and 
high dose (3E) estradiol replacement. Negative values indicate a phase delay and positive 
values indicate a phase advance. Significant differences are indicated with *, a relative to 
b, p<0.05.  Sample sizes for the groups as follows: For ZT4, WT (n=5-7/group), NERKI 
(n=6-9/group), and ERKO (n=6 for gdx, n=3 for E, and n=4 for 3E). For ZT16, WT 
(n=7-8/group), NERKI (n=8-10/group), and ERKO (n=7 for gdx, n=2 for E, and n=2 for 
3E). For ZT22, WT (n=5-8/group), NERKI (n=6-9/group), and ERKO (n=6 for gdx, n=3 
for E, and n=7 for 3E). 
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CHAPTER 5 
 
Over-expression of estrogen receptor subtype 1 (ESR1) influences the expression of 
circadian parameters in adult mice 
 
 
 
Abstract: 
Biological rhythms are critical for the timing of hormone secretion, reproduction, and 
rest-wake activity patterns. Activity rhythms are modified by gonadal hormones, 
including estrogens, but relatively little work has characterized how hormone 
environment during development shapes the expression of circadian rhythms in adult 
animals. We hypothesized that daily activity patterns are modified by estradiol acting on 
estrogen receptor subtype 1 (ESR1) during development and adulthood. To test this we 
used transgenic ESR1 over-expressing (EROE) mice and their control littermates. We 
used male and female intact, gonadectomized, and estradiol-replaced mice. Results 
indicate sex-differences and a role of hormonal environment during development on the 
expression of circadian rhythms in adulthood. Gonadectomized male and female mice 
that developed with a hypersensitivity to estradiol were more diurnal than control 
littermates. In gonadectomized animals, only female EROE animals had significantly 
higher levels of activity than control littermates, whereas there was no difference between 
genotypes in males. Gonadectomy decreased wheel-running activity in all groups of 
animals relative to intact counterparts. These data suggest that estradiol acts via both 
acute and organizational mechanisms to modify the expression of circadian patterns of 
behavior and entrainment to light. Identifying the mechanism of estrogenic regulation of 
circadian behavior will help to understand the etiology of sex differences in circadian 
rhythms and the pathologies associated with circadian disruption. 
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Introduction: 
Gonadal hormones modify the expression of circadian rhythms and activity 
patterns in mammals, including daily activity level, distribution of wheel-running across 
the day, and the duration of the free-running period (Albers, 1981, Davis et al., 1983). 
Hormones are classically described as acting via two distinct mechanisms: activational 
effects and organizational effects (Arnold and Breedlove, 1985). Activational activity of 
hormones includes transient changes in the brain and behavior that occur in the presence 
of the hormone. The activational effects of estradiol modification of circadian rhythms 
have been described. The changes in activity level and distribution and the duration of the 
free-running period have been characterized over the rodent reproductive cycle. On days 
of high circulating estrogens, animals have an advanced phase angle of activity onset, 
increased activity level in light-dark (LD) conditions, and decreased free-running period 
in constant conditions (Fitzgerald and Zucker, 1976, Morin et al., 1977a, Albers et al., 
1981, Wollnik and Turek, 1988, Labyak and Lee, 1995). Further, estradiol replacement in 
gonadectomized female rats, hamsters, and degus advances the time of daily activity 
onset and increases activity levels relative to animals without estradiol replacement 
(Gentry and Wade, 1976, Morin et al., 1977b, Albers, 1981, Labyak and Lee, 1995). 
In contrast to activational effects of hormones, organizational effects persist after 
the hormone is no longer present and occur when an organism is exposed to a hormone 
during a critical period or during development. Differential steroid hormone exposure 
during development alters the expression of activity patterns and circadian rhythms in 
adulthood. Mice that cannot produce estradiol and mice that have impairments in normal 
functioning of estrogen receptors have altered circadian rhythms relative to wildtype 
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counterparts that persist in gonadectomized animals. Aromatase knock-out mice, that 
cannot produce endogenous estradiol, show decreased total activity, increased 
fragmentation of activity, and altered phase response to light pulse relative to wildtype 
(WT) mice (Brockman et al., 2011). However, the mechanisms of this hormonal 
regulation are not fully understood. 
There is evidence that estrogens acting at estrogen receptor subtype 1 (ESR1), or 
estrogen receptor alpha, modify the amplitude of daily activity and the distribution of 
wheel-running across the LD cycle. Activity level is regulated by estrogens acting at 
ESR1 (Ogawa et al., 2003). Additionally, unpublished work from our lab indicates that 
intact ESR1 knock-out mice have increased activity during the light phase of an LD cycle 
and differences in behavioral response to light pulse relative to WT mice. Together, these 
data indicate that estrogens acting at ESR1 organize circadian rhythms in entrainment and 
modify behavioral response to light pulse. However, how and where estradiol acts during 
development and in adulthood to modify the expression circadian rhythms and activity 
patterns is not fully understood.  
While we have seen that impaired ability to respond to estrogens over the lifetime 
alters behaviors, it is unknown if heightened exposure similarly alters rhythms. 
Determining the effects of heighted exposure to estrogens, or increased ability to respond 
to circulating estrogens, has implications both for understanding the role of normal, 
endogenous steroid hormones on the organization of circadian rhythms, but also for 
understanding potential effects of exposure to estrogenic agents from the environment, 
such as genistein and bisphenol A. We hypothesize that heightened responsiveness to 
estrogens at ESR1 will alter daily activity patterns and circadian rhythms, by increasing 
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the level of daily activity and consolidating activity to the dark phase. To test this 
hypothesis, we used ESR1 over-expressing mice (Tomic et al., 2007). It is known that 
estrogens binding their receptors are critical for normal development and maintenance of 
the female reproductive tract and normal estrous or menstrual cyclicity. However, the 
effects of increased exposure to estrogens or increased responsiveness to estrogens on 
activity patterns and circadian rhythms are unknown.  
We used transgenic male and female mice that express high levels of ESR1, 
estrogen receptor over-expressers (EROEs), to test the hypothesis that estrogen exposure 
during development modifies biological rhythms via this receptor. We hypothesize that 
heightened responsiveness to estrogens via increased expression of ESR1 will influence 
circadian entrainment in EROE mice when compared to control animals. Characterizing 
circadian parameters in ESR1 over-expressing transgenic mice will provide evidence that 
estrogens modulate circadian entrainment via action at ESR1.  
 
Methods: 
Animal Breeding and Care 
Male and female EROE and control animals were a kind gift from Dr. Jodi Flaws 
(University of Illinois, Urbana, IL) and were generated using C57BL6 and FVB mice as 
previously described (Tomic et al., 2007). Breeding animals and litters were maintained 
on Teklad 8626 rodent diet. Prior to activity monitoring, adults were given a Teklad 2016 
diet, which contains low soy estrogens (isoflavones) in the range of non-detectable to 20 
mg/kg, and remained on this diet for the remainder of the studies. They were given food 
and water ad libitum. 
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 Adult mice (>2 months) remained intact, were gonadectomized, or were 
gonadectomized and given silastic capsules containing estradiol benzoate. We used the 
following groups: EROE and control female intact, ovariectomized, and ovariectomized 
with estradiol replacement (n=7-8/group), and control and EROE male intact and 
gonadectomized mice (n=7-8/group). Silastic capsules (1 cm length, 1.02 mm inner 
diameter) were implanted subcutaneously in the replacement groups, with either one or 
three capsules for low and high dose, respectively. Capsules contained 1 mg/mL estradiol 
benzoate in sesame oil as described (Christian et al., 2005, Robertson et al., 2009). 
 Mice were individually housed in cages (28 x 16 x 12cm) equipped with a metal 
wheel affixed to the top of the cage. Wheel revolutions were registered by a magnetic 
switch and recorded in 10-minute bins of activity. Wheel-running activity was recorded 
and data was visualized using VitalView and ActiView (MinitMitter, Eugene, OR). Mice 
were maintained in 12 hour light:12 hour dark cycles unless otherwise indicated. The 
light intensity in the cages ranged from 220-360 lux (average 290 lux). All animal 
procedures were approved by the Institutional Animal Care and Use Committee of the 
University of Illinois and were conducted in accordance with the NIH Guide for the Care 
and Use of Laboratory Animals. 
 
Determination of Daily Activity Patterns and Circadian Parameters 
The following circadian variables were determined for intact animals and 
gonadectomized animals with and without estrogen replacement: average daily wheel 
revolutions, light:dark ratio, and duration of free-running period (tau) in constant dark 
(DD) conditions. Tau in constant light (LL) was also determined for intact and 
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gonadectomized males and females. Activity was measured as wheel-running, collected 
into 10-minute bins. Activity was defined as each bin showing greater than 10 percent of 
the bin with the peak daily activity.  
The total daily activity was calculated based on five consecutive days in 12:12 LD 
entrained light cycle. For each individual, the total number of wheel revolutions over 24-
hours was averaged across five days. These averages were then used to calculate the 
group averages for each genotype and sex.  
The LD ratio represents the activity during the light phase relative to the dark 
phase. LD ratios close to 0 represent exclusively nocturnal animals. LD ratios were 
calculated from 5 consecutive days during a 12:12 light-dark cycle for each individual, 
and values for individuals were averaged to determine the LD ratio for each group. 
The free-running period (tau) was recorded in constant dark and light conditions. 
The free-running period was measured for animals in constant conditions for at least 7 
days. The tau value was obtained from a periodogram analysis of wheel running activity 
in ActiView. 
 
Statistical Analysis 
 Total daily activity, LD ratio, and tau in constant conditions were analyzed for 
each sex with a two-factor ANOVA, using hormone treatment and genotype as 
independent factors (SYSTAT). Variables were then analyzed within a treatment group, 
using sex and genotype as independent factors. A priori post hoc two-sample 
comparisons were performed to determine differences between groups. Differences were 
significant when p < 0.05. 
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Results:  
Total activity depends on sex, genotype, and treatment 
We tested for effects of treatment and genotype on total activity within males and 
females (Figure 26). In females, there was a significant effect of genotype 
[F(2,47)=3.346, p=0.044] and treatment [F(3,47)=6.376, p<0.01] on total activity; EROE 
mice had greater activity than control mice when collapsed across treatment groups. 
There was no interaction between genotype and treatment on total activity. 
Ovariectomized EROE females had significantly greater total activity than 
ovariectomized control females (p<0.05). In males, however, there was only an effect of 
treatment on total activity [F(1,20)=22.564, p<0.01]; gonadectomized males had 
decreased activity relative to intact males. There was no effect of genotype or interaction 
between genotype and treatment, although the interaction approaches significance 
[F(1,20)=4.03, p=0.058]. In intact animals, EROE males had decreased activity relative 
to control males (p<0.05). Following gonadectomy, this genotype difference in males 
was abolished. Gonadectomy caused a significant reduction in activity in control males 
and females and EROE females (p<0.05) but not EROE males. 
Within treatment groups, we tested for effect of sex and genotype on total 
activity. In intact animals, there was a significant effect of sex on total wheel-running 
activity [F(1,23)=9.408, p<0.01] with females having increased activity relative to males. 
There was no effect of genotype. Among gonadectomized animals there were significant 
effects of sex [F(1,21)=12.378, p<0.01] (females had greater activity than males) and 
genotype [F(2,21)=4.299, p=0.027] on total activity. There were sex differences in total 
 
     
 
 
123 
wheel-running activity in intact EROE mice, but not control mice. EROE females had 
greater total activity (28,000 ± 4,000 revolutions) than EROE males (12,000 ± 2,000 
revolutions, p<0.05). 
Gonadectomized animals and animals with low dose estradiol (1E) replacement 
did not have significantly different activity levels. High dose estradiol replacement (3E) 
restored both control and EROE female total activity to intact levels and significantly 
increased activity relative to ovariectomized animals without estradiol replacement 
(p<0.05). As with intact females, there was no significant difference between control and 
EROE animals with high dose estradiol replacement. 
 
LD ratio depends on sex, genotype, and treatment 
The LD ratio describes the amount of activity during the dark phase relative to the 
amount of activity during the dark phase of a light-dark cycle. Two-factor ANOVAs with 
treatment and genotype as independent variables were used to evaluate LD ratio among 
females and males separately (Figure 27). Among females, there was a significant effect 
of treatment [F(3,45)=16.54, p<0.01], with gonadectomized animals having increased LD 
ratio relative to intact females and females with high dose estradiol replacement. There 
was also a significant effect of genotype [F(2,45)=12.025, p<0.01] on LD ratio and 
control females had lower LD ratios than EROE females. There was an interaction 
between treatment and genotype in LD ratio [F(2,45)=5.457, p<0.01]. Among males, 
there was a significant effect of genotype [F(1,19)=11.329, p<0.01]; the LD ratio of 
EROE males was greater than control males. There was no effect of treatment or an 
interaction between treatment and genotype. 
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We also tested for an effect of sex and genotype for intact and gonadectomized 
animals. Among intact animals, there was an effect of sex on LD ratio [F(1,22)=21.731, 
p<0.01]; female LD ratio was decreased relative to males. Specifically, there were sex 
differences in LD ratio in intact EROE, but not in intact control mice: the LD ratio of 
intact male EROE mice (1.3 ± 0.24) was greater than female EROE mice (0.3 ± 0.06. p< 
0.05). The effect of genotype on LD ratio did not reach significance [F(2,22)=3.265, 
p=0.057]. In intact males and females there were no genotype differences in LD ratio (in 
males, this approached significance p=0.059.) 
Conversely, among gonadectomized animals there was a significant effect of 
genotype [F(2,20)=9.844, p<0.01], but no significant effect of sex on LD ratio. 
Ovariectomized EROE females had a significantly greater LD ratio (0.7 ± 0.11) than 
control females (0.4 ± 0.07, p < 0.05). There was a similar pattern in males: 
gonadectomized EROE males had significantly greater LD ratio than control counterparts 
(p< 0.05). In EROE females, ovariectomy increased LD ratio relative to intact animals 
(p< 0.05). However, in all other groups, there was no difference in LD ratio in intact 
compared to gonadectomized animals. Though not significant, in males, the trend was in 
the opposite direction (gonadectomy consolidates activity to the dark phase). 
Among females with high dose estradiol replacement, activity was consolidated to 
the dark phase for both control and EROE mice. EROE females had significantly greater 
LD ratio than control females with 3E estradiol replacement (p<0.05). Like with total 
activity, the low dose (1E) did not significantly alter the consolidation of activity relative 
to counterparts with no estradiol replacement. 
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Free-running period in DD does not depend on sex, genotype, or treatment 
The duration of the free-running period, tau, was determined in constant darkness 
(Figure 28). Two-factor ANOVAs were performed to identify effects of treatment and 
genotype on DD tau within males and females. There were no significant effects of 
treatment or genotype among either males or females. A two-factor ANOVA within 
treatment groups identified no significant effect of either sex or genotype on free-running 
period in DD. In control mice, however, intact males had a shortened tau relative to 
gonadectomized males (p<0.05). There were no other significant differences between 
groups.  
 
LL tau depends on genotype and treatment, but not sex 
Differences in the free-running period in constant light were analyzed using two-
factor ANOVAs with genotype and treatment status as independent factors (Figure 29). 
Within females, there was a significant effect of genotype on LL tau [F(1,23)=5.251, 
p=0.031], but no effect of treatment or an interaction between treatment and genotype. In 
contrast, in males, there was an effect of hormone status [F(1,23)= 5.39, p=0.029], but no 
effect of genotype or an interaction between genotype and hormone status. Among 
females, intact EROE animals had a significantly longer free-running period than intact 
control animals (p<0.05). The free-running period in LL did not differ in ovariectomized 
EROE and control females. Gonadectomized males had increased free-running period 
relative to intact animals in control but not EROE mice (p<0.05). Finally, there were sex 
differences in the free-running period in LL; intact EROE females had a significantly 
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greater free-running period than intact EROE males. This sex difference was not seen in 
intact control groups or either gonadectomized control or EROE animals. 
 
Discussion: 
 We characterized the activity patterns during entrainment and the circadian 
rhythms in constant conditions in male and female EROE mice and their WT littermates. 
Our results reveal both acute and organizational effects of estrogen responsiveness on the 
expression of daily activity and circadian rhythms in adulthood. Gonadectomy 
significantly reduces total daily wheel-running activity in female control and EROE and 
male control mice relative to intact counterparts (Figure 26). Interestingly, 
gonadectomized male EROE mice with heightened response to estrogens during 
development did not show a significant decrease in activity levels relative to intact EROE 
males, although it is possible that this could be due to relatively low total activity overall. 
Further, we found that circulating gonadal hormones consolidate activity to the dark 
phase in female EROE and control mice (Figure 27). Gonadectomy significantly 
increases LD ratio in EROE animals relative to intact mice and high dose estradiol 
replacement consolidates the activity in both EROE and control females.  
We also found evidence for a developmental role of heightened responsiveness to 
estrogens, as there are significant differences in daily activity level and distribution 
between control and EROE mice following gonadectomy. In ovariectomized females, 
EROE mice have increased wheel-running activity relative to control mice (Figure 26). 
This estrogenic modification of activity levels appears sex-specific as there is no 
difference in the level of activity between gonadectomized EROE and control males. In 
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both female and male gonadectomized animals, EROE mice have a significantly greater 
ratio of activity during the light relative to the dark phase than control mice (Figure 27). 
This difference in activity distribution across the LD cycle is not apparent in intact mice, 
as there are no statistically significant differences between genotypes in intact animals. 
Estradiol has an activational role on total daily activity and activity patterns; for 
example, activity levels fluctuate across the stages of the reproductive cycle in rodents 
(Morin et al., 1977a, Albers et al., 1981, Wollnik and Turek, 1988, Labyak and Lee, 
1995). These changes in activity are dependent on estradiol, as shown by hormone 
replacement to gonadectomized animals (Morin et al., 1977b, Albers, 1981, Labyak and 
Lee, 1995). In adult animals, total wheel-running activity depends, in part, on estrogenic 
action at ESR1. Previous unpublished data from this lab suggest that activational effects 
of estrogens, specifically via ESR1, increase total activity and consolidate activity to the 
dark phase. Total wheel-running activity depends on estrogenic action at ESR1 (Ogawa 
et al., 2003). While the circadian behavior of the mouse FVB background has been 
described as variable (Pugh et al., 2004), we still see significant differences in activity 
depending on genotype and treatment. Our data further illuminate the role of estrogens in 
modifying activity levels. In females, heightened response to estrogens during 
development causes an increase in wheel-running activity even in the absence of 
circulating hormones in adult animals. This suggests that estrogens, specifically estrogens 
acting via ESR1, modify adult activity levels at a critical period during development. 
Estrogenic responsiveness over the lifetime modifies patterns in activity level and 
distribution such that, in the absence of circulating estrogens, the behaviors are different 
between EROE and control mice. 
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In addition to determining daily patterns in activity during LD entrainment, we 
also characterized the free-running rhythms of male and female EROE and control mice. 
In constant darkness, the free-running period of female mice does not significantly differ 
among treatment or between genotype (Figure 28). In rats and hamsters, tau is shortened 
when animals have high circulating estradiol concentrations (Morin et al., 1977a, Albers 
et al., 1981). Studies in rats, hamsters, and mice show that tau is increased by 
gonadectomy and decreased by estradiol replacement (Daan et al., 1975, Morin et al., 
1977b, Albers, 1981). Here we did not find a significant increase in tau in ovariectomized 
females relative to intact mice or a decrease in tau in mice with estradiol replacement 
relative to no hormone replacement. However, the variability in these groups could 
account for this, as the average duration of tau is increased in gonadectomized female 
mice when genotypes are combined. Gonadectomized control males have a longer tau 
relative to intact control males. In contrast, gonadectomy has no significant effect on tau 
in EROE males. In contrast to tau in constant darkness, we found significant differences 
among the free-running periods of intact control and EROE mice in constant light (Figure 
29). In intact females, EROE mice have and increased tau relative to control mice. There 
is also a sex difference in tau in intact EROE mice; EROE females have longer free-
running period than males. In gonadectomized mice, these differences are not present.  
Together, these data indicate activational and organizational effects of estrogens 
on the expression of adult activity patterns and circadian rhythms. Characterizing how 
heightened responsiveness to estrogens influences the expression of circadian rhythms 
has implications for understanding how daily activity might be influenced by exposure to 
environmental estrogens and how differential responses to estrogens modify circadian 
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and daily activity. Further, sex differences in activity patterns may indicate different 
mechanisms of estradiol action during adulthood and development that shape the 
organization of daily activity. These divergent mechanisms of estradiol mediation of 
circadian rhythms and activity patterns will help to better understand sex differences in 
human circadian rhythms and how gonadal hormones regulate circadian rhythms. 
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Figure 26: Total wheel-running activity (± SEM) in control and EROE female (left) and 
male (right) mice. Intact EROE females have greater activity than intact EROE males (a 
relative to b, p<0.05). Ovariectomized female EROE mice have increased activity relative 
to control mice (c relative to d, p<0.05). * indicates p < 0.05 for paired comparisons. 
Sample size was 7-8/group. 
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Figure 27: Average LD ratio (± SEM) for female (left) and male (right) control and 
EROE mice. Intact EROE females have decreased LD ratio relative to intact EROE males 
(a relative to b, p<0.05). For both females and males, gonadectomized EROE animals 
have increased LD ratios relative to control animals (c relative to d and e relative to f, 
respectively, p<0.05). Differences among treatment groups within sex and genotype are 
indicated by * (p < 0.05). Sample size was 7-8/group. 
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Figure 28: Free-running period, tau (± SEM), in constant darkness of female (left) and 
male (right) control and EROE mice. Among control males, gonadectomy increases tau * 
p < 0.05. Sample size was 7-8/group. 
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Figure 29: Duration of the active period, alpha (± SEM), in constant light of female (left) 
and male (right) control and EROE mice. Intact EROE females have increased alpha 
relative to intact EROE males (a relative to b, p<0.05). Significant differences are 
indicated by * (p < 0.05). Sample size was 7-8/group. 
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SUMMARY AND SYNTHESIS 
Data from these studies indicate organizational and activational mechanisms of 
estrogenic regulation of circadian rhythms and daily activity patterns in male and female 
mice. In these studies, I characterized the daily activity patterns during light-dark 
entrainment, circadian rhythms in constant conditions, and behavioral phase response to 
light pulses in male and female mice with transgenic alterations in their ability to respond 
to estrogens at estrogen receptor subtype 1 (ESR1). These results demonstrate that 
estrogens modulate the expression of activity patterns via activational and organizational 
mechanisms through both classical estrogen response element (ERE)-mediated and non-
classical (ERE-independent) action at ESR1. 
Estrogenic modulation of total daily activity level and the distribution of activity 
in the light relative to the dark phase are primarily mediated via activational effects of 
estrogens at ESR1. Intact NERKI and ERKO females have decreased activity relative to 
WT females (Chapter 1). Estradiol replacement to ovariectomized females increases 
activity in WT, but not ERKO mice (Chapter 3). Interestingly, NERKI females have 
intermediate activity levels to WT and ERKO littermates. Although the magnitude of the 
difference in less in males, the patterns follow those of the females (Chapter 4). This 
suggests that in both males and females, the level and distribution of daily activity are 
modulated by both classical and non-classical estrogenic action at ESR1. In females, but 
not males, heightened responsiveness to estrogens over the lifetime modifies daily 
activity in the absence of circulating gonadal hormones. Ovariectomized EROE females 
have decreased activity relative to ovariectomized control females (Chapter 5). 
Additionally, in both males and females, heightened responsiveness to estrogens over the 
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lifetime may alter the activity distribution in the absence of circulating gonadal hormones 
(gonadectomized control animals are more nocturnal than gonadectomized EROE mice). 
These differences indicate that there are also developmental effects of responsiveness to 
estrogens on the level and distribution of daily activity. 
Our data indicate an interesting sex difference in the effect of estradiol on the 
phase angle of activity onset relative to the dark phase. Among females, estradiol-treated 
NERKI, ERKO, and WT mice have advanced onset of activity relative to females 
without hormone treatment (Chapters 3 and 4). Together with data from intact females 
that show no differences between genotype, this suggests an ESR1-idependent 
mechanism of estrogenic modification of activity phase angle. In males, however, non-
classical actions of estradiol at ESR1 modulate the phase angle (intact NERKI males 
have a delayed phase angle relative to both WT and ERKO mice) and estradiol 
replacement to gonadectomized NERKI males, but not WT or ERKO males, advances the 
phase angle of activity onset. These effects appear to be primarily activational, as there 
are not genotype differences in gonadectomized animals that lack circulating gonadal 
hormones. 
In both males and females, estradiol action at ESR1 acting via classical and non-
classical mechanisms shortens the free-running period in constant darkness. Estradiol 
replacement to gonadectomized male and female animals decreases tau in WT, but not 
ERKO mice (Chapters 3 and 4). Similar to my findings for activity levels, NERKI mice 
of both sexes are intermediate to WT and ERKO mice. In mice with heightened 
responsiveness to estrogens at ESR1, gonadectomy increases tau in males and females 
relative to intact animals (Chapter 5). In females, estradiol treatment shortens tau to 
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levels of intact animals (males in this study were not given estradiol treatment). The 
duration of the active period was modified by activational and organizational effects of 
estrogens at ESR1 in females (and to a lesser extent in males). 
Finally, in intact mice, there is a sex-specific effect of genotype on the phase 
response to light pulses (Chapter 2). There are significant differences in the magnitude of 
the phase response to light pulses given early and late in the subjective night that depend 
on both classical and non-classical actions of estrogens at ESR1 in females only. 
Together, these data elucidate mechanisms of estrogenic modification of circadian 
rhythms. Estrogens acting at ESR1 modify circadian parameters both via organizational 
and activational effects. Better understanding the sex differences in the hormonal 
regulation of the expression of daily activity patterns and circadian rhythms helps to 
elucidate mechanisms that underlie sex differences in human circadian rhythms and the 
etiology of sleep disorders.  
